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ABSTRACT 
Recurrent implantation failure (RIF) is the failure of the embryo to implant. 
Embryonic causes of RIF have been studied intensely; recently, investigations of 
endometrial causes of RIF have emerged. 
‘Natural Killer’ cells appear in large numbers in the endometrium towards the mid-
secretory phase, during the ‘window of impanation’. Their role in recurrent 
implantation failure needs investigating. 
There are two competing hypotheses regarding the origin of uNK cells. They are 
either the result of proliferation of resident uNK cells or are from the trafficking of 
peripheral blood cells into the uterus and their subsequent differentiation into their 
uNK form.  
Endometrial biopsies from 19 patients, 10 ‘low’ density uNK and 9 ‘high’ density 
uNK were stained using immunohistochemisty to compare antibodies associated 
with trafficking: L-Selectin, with a marker for peripheral blood NK cells, CD16, 
against makers for proliferation Ki67 and differentiation NKp30, on endometrial 
tissue, using CD56 as the universal marker for natural killer cells. The endometrial 
tissue will be obtained 7 days after the LH surge in the luteal phase as this is the 
window of implantation. Variation in location of these cells within samples was also 
studied in the following areas: sub-epithelial, areas with low stromal density and 
perivascular stroma in both groups. 
Differences in percentage cell density was observed between both groups, as 
expected. With both groups observing more positively stained cells of each 
antibody in perivascular areas. 
Few numbers of CD62-L and CD16+, markers for trafficking cells were detected. This 
suggests that uNK cells are not migrating in from peripheral blood, but arising from 
the endometrium, possibly from heamatopoietic cells. 
CD56+ cells were seen in higher in areas around vessels than in other locations 
(p=0.003). Their close proximity to vessels enables them to promote vasculature 
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development. The markers for proliferation and differentiation of uNK cells, Ki67 
and NKp30 was also significantly higher in areas around vessels compared to areas 
near epithelium (p=0.006 and p=0.023 respectively). 
Perhaps this early development of arteries leads to a highly oxygenated state, which 
is detrimental to the developing embryo. 
The paucity of trafficking markers indicates that uNK cells are not trafficking from 
the peripheral blood, so peripheral blood testing is of no clinical value in patients 
with recurrent implantation failure. 
The consistent perivascular location of these cells indicates that these proliferating 
and differentiating cells have a role in vascular remodelling, which, may lead to a 
highly oxygenated state, decreasing the receptivity of the endometrium and causing 
implantation failure. 
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CHAPTER 1 – INTRODUCTION AND LITERATURE REVIEW 
1.1 Infertility 
1.1.1 Definition 
Infertility refers to a couple’s inability to conceive after a year of regular, 
unprotected intercourse in the fertile phase of the menstrual cycle (1).  Impaired 
fertility affects 10-15% of couples (2). It is estimated that on average 7 couples per 
year per average sized general practice in the UK seek medical advice for fertility 
problems (3). A large population based study of UK women (n=60,000) found a life 
time prevalence of infertility to be as high as 2.4%, with no difference among birth 
cohorts, despite advances in medical treatment (2). 
 
Couples who are diagnosed as being infertile experience many difficulties, putting a 
strain on their relationship. Psychological stresses stem not only from the social and 
personal burden of not being able to have children, but also from the many 
investigations and numerous visits to the hospital. Treatment schedules become the 
main focus of time spent, and patients also may experience behavioural changes 
due to treatment drugs (4). When these treatment attempts fail, it can be 
devastating for couples and strength emotionally and financially to attempt 
treatment again may not be available.  
 
Infertility can be regarded as either primary or secondary, with primary infertility 
referring to a woman never having conceived before and secondary when she has 
previously been pregnant, regardless of the outcome of the pregnancy. 
In order for conception to take place the following conditions must be present(5): 
 The Ovum: ovulation must occur in the female, annovulation is responsible 
for approximately 30% of cases of infertility. 
 Sperm: Adequate quantities of ‘good quality’ sperm must be produced. 
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 Sperm must reach the egg: Sperm must be able to travel from their source 
of production, the male testis, to the site of the ovum, usually in the 
fallopian tube of the female, in order for fertilisation to take place. 
 Implantation: the fertilised egg must be able to implant in the endometrium 
for a viable pregnancy to occur. Defective implantation may be as high as 
30%. 
Investigating inability to conceive is usual after one year of unprotected intercourse, 
and just six months in couples where the woman is over the age of 35. Initial 
investigations may reveal a source for the infertility, divided into male and female 
factors (6). 
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1.1.2 Aetiology 
1.1.2.1 Male factor infertility 
Male factor infertility accounts for 32.5% of infertility of all infertility(7).  
Disorders of spermatogenesis: 
Spermatogenesis is controlled by the hypothalamic-pituitary-axis (see Figure 1 
below), producing follicle-stimulating-hormone (FSH) and leutinising hormone (LH). 
LH stimulates the release of androgens by leydig cells in the testis, FSH stimulates 
sertoli cells to secrete inhibin which acts as negative feedback on the production of 
FSH. Spermatogenesis, governed by genes located on the Y chromosome, is the 
division of spermatogonia into spermatocytes, whereas spermiogenesis is the 
transformation of spermatogonia into spermatozoa (8).  
 
 
 
 
 
 
 
 
 
 
Figure 1: Hormonal regulation in sperm production. Adapted from Human Embryology(8). 
Disorders of spermatogenesis may arise when scrotal temperatures rise, due to 
undescended testes, varicocele, hot baths or tight underwear (9). Microdeletions of 
Hypothalamus 
Sertoli Cell 
Inhibin 
Leydig Cell 
FSH+ 
Pituitary 
LH+ 
LHRH 
Testosterone 
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the Y chromosome may also lead to impaired sperm production (10). Also the 
following medications may have a negative effect: psychotropic drugs, 
antiepileptics, antihypertensive and antibiotics (11). 
Impaired sperm motility and transport: 
Spermatozoa, released in the lumen of the seminiferous tubules do not gain their 
motility until they reach the ampulla of the vas deferens. During ejaculation the 
semen is released comprising of these spermatozoa and secretions from the 
prostatic seminal vesicles (5). 
Altered motility may be the result of congenital malformations of the epididymis or 
obstruction due to infection and an inflammation or vasectomy.  
Ejaculatory dysfunction: 
This can be caused by medications, recreational drug use, idiopathic or caused by 
metabolic and systemic diseases. 
Immunological and Infective factors: 
Mumps, caused by the mumps virus (a rubulavirus (12)). Can affect male fertility if it 
causes orchitis. 
Sexually transmitted disease 
Although uncommon in western countries, sexually transmitted diseases can affect 
male fertility, as well as female. Chronic infection with Neisseria Gonorrhoea and 
Chlamydia Trachomatis can cause damage to urethral structures and lead to 
epididymo-orchitis. Also Ureaplasma Urealyticum may impair spermatozoa (motility 
and DNA condensation), and HIV affects the quality of semen (13). 
Male infection with Neisseria Gonorrhoea and Chlamydia Trachomatis can easily 
spread to the female partner and damage fallopian tubes through pelvic 
inflammatory disease (14).  
It is necessary to test and treat for any of these infections, which if caught early, can 
be treated successfully with no long-term injury to reproductive structures.  
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1.1.2.2 Female Factor Infertility 
Disorders of ovulation: 
An intact hypothalamic-pituitary-ovarian axis is necessary for ovulation. Pulsatile 
GnRH release from hypothalamus stimulates the pituitary to release the hormones 
FSH and LH, which in turn stimulate the maturation of follicles within the ovary, and 
following a surge in LH on day 14 of the menstrual cycle, ovulation occurs. 
Impairment in ovulation can occur at any point from the hypothalamus to the 
ovary.  
Several conditions may affect the pulsatile release of GnRH, from psychological 
stress to structural lesions, including prolactinomas, and systemic conditions such as 
thyroid disease, which may consequently lead to annovulation. Polycystic Ovarian 
Syndrome (PCOS) is the most common cause of annovulation. 
Impaired oocyte production: 
Turner’s syndrome: Patients with Turner’s syndrome have gonadal dysgenesis 
which leads to amenorrhoea and sterility (15). 
Premature ovarian failure: these patients undergo an early menopause, before the 
age of 40, either genetic in nature, idiopathic or the result of an oophorectomy, 
medically indicated for disease, or similarly radiation, chemotherapy to the pelvic 
region (16). 
Tubal Dysfunction: 
This has a higher prevalence in populations where sexually transmitted infections 
are higher, as secondary subfertility. Chlamydia Trichomatis is the main organism 
that leads to cilia lining the lumen of the fallopian tubes to become damaged and 
thus impair oocyte transportation to the ampulla. 
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Disorders of implantation: 
These factors relate to the endometrium, the site of blastocyst implantation, 
defects in its development of growth and adhesion molecules may produce a 
barrier to implantation. It is also thought that structural disorders within the uterus 
such as fibroids prevent or hinder the implantation of the embryo into the uterine 
wall(17). 
 
1.1.2.3 Unexplained Infertility 
Unexplained infertility accounts for 23.1% of infertility (7). Where causes cannot be 
found in the rest of the male or female reproductive fact, the problem in conceiving 
may lie within the endometrium itself (18). Endometrial receptivity has been looked 
at in depth (19), with various hypotheses to potential pathology. It is currently not 
known what major endometrial factor contributes to unexplained implantation 
failure. 
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1.1.3 Treating Infertility 
Addressing causative features: 
Initial management of these patients should involve taking a comprehensive history 
and conduction of a full investigation, identifying whether it may be a male or 
female factor or mixed, and isolating it and tailoring treatment accordingly. 
Assisted Conception: 
Assisted conception techniques have been around since the 1970s (7), and have 
enabled over a million babies to be conceived. The technique centres in allowing 
the ovum and the sperm to be in close proximity to enable fertilisation to take 
place. 
The most commonly used methods in current practice are intrauterine 
insemination, in vitro fertilisation and intracytoplasmic sperm injection (ICSI). 
Steps in assisted reproduction: 
Pituitary down-regulation:  
This is necessary to prevent the natural LH surge mid-cycle from causing follicular 
rupture prior to egg retrieval; this is achieved with the use of GnRH analogue. 
Ovarian Stimulation 
This is achieved by daily injections with gondaotrophins for 11-14days until the 
follicles are 18mm in diameter on transvaginal ultrasound. To trigger ovulation an 
injection of hCG is used in replace of LH to trigger ovulation, approximately 34-36 
hours later, these eggs are retrieved in their follicular fluid via a controlled vacuum 
pump.  
Insemination: 
Isolated sperm, having undergone a washing procedure to remove unwanted 
leukocytes, bacteria and seminal plasma, are incubated with the egg 4-6 hours after 
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collection, for 16-18 hours. ICSI requires an additional step to remove the 
surrounding cumulus cells surrounding the oocytes. 
48 hours after culture the embryos are examined for cleavage and are graded, 
those with minimal fragmentation are scored more highly than those with any 
fragments. 
Embryo transfer: 
Embryos are transferred using a transcervical catheter on the second or third day of 
culture. Only two embryos are allowed to be transferred in each cycle in the UK, to 
minimise the complication of multiple births. However, in exceptional 
circumstances, for instance increasing maternal age, a limit of three embryos per 
transfer is allowed (7).  
Any spare embryos of good quality can be stored via cryopreservation and used at a 
later date in frozen cycles. Two-thirds of embryos survive the thawing process. 
Luteal support can be given in the form of progesterone supplements or low-dose 
hCG. 
Pregnancy is screened for by a urinary pregnancy test of serum β-hCG analysis 14 
days after embryo transfer. 
Complications: 
IVF is not without complications, the risk of multiple pregnancy is higher than with 
natural conception, this is minimised by limiting the number of embryos transferred 
to two and careful monitoring throughout ovarian stimulation. Multiple pregnancy 
rates from IVF have remained steady over the past 15 years, around 24% (7) 
multiple births increase the morbidity and mortality rate for the mother and her 
offspring resulting in great healthcare costs. Ovarian hyper-stimulation syndrome 
arises as a result of an exaggerated response to exogenous gonandotrophins, and is 
more common in those women who produce 20 or more follicles or those who have 
PCOS. Patients who develop this may need inpatient care.  
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Four per cent of pregnancies arising from IVF treatment result in ectopic 
pregnancies, with an increased risk in patients who have a history of tubal disease 
or damage.  
Despite advances in technology unfortunately 4 per cent of couples will remain 
infertile. 
Most causes of infertility can be isolated and subsequently treated for, with many 
patients finding the solution in using in vitro fertilisation (IVF), however for those 
where there is a problem in implantation, this is not a solution. As methods of 
assisted reproduction can only go so far, allowing the ovum and sperm to meet and 
for fertilisation to take place, it cannot enhance the receptivity of the uterus. This 
limiting factor must be investigated. 
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1.2. Menstrual Cycle(5) 
Hormonal regulation of the menstrual cycle prepares the endometrium for 
implantation if fertilisation occurs.  
The implantation window, days 7-10 after LH surge, signifies the period in which 
implantation is most likely to occur (20). By this point the endometrium has 
undergone significant changes to enhance its receptivity to the embryo. A surge in 
LH secreted from the anterior pituitary causes egg release from the mature follicle, 
ovulation, seven to nine days later is the ideal time for implantation to occur (20). 
Under the governance of the gonadotrophins, LH and FSH, the endometrium lining 
proliferates with vascular changes.  
Structural Changes to Enable Implantation: 
Menstruation: Days 1-4 
The lack of implantation stimulates the corpus luteum to lower production of 
hormones, withdrawing support for the endometrium.  The tunica media of the 
spiral arteries contract, ceasing blood supply to the tissue, necrosis follows and the 
endometrium is shed, along with blood which has not coagulated due to a local 
fibrinolytic.  
The proliferative phase: days 5-13  
FSH release from the anterior pituitary causes follicular growth, which in turn leads 
to secretion of oestradiol, which causes the endometrium to develop, proliferate, 
with intense mitosis in the stroma and glandular epithelium, and re-form following 
menstruation (start of which is day 0). Early during this phase the surface 
epithelium re-forms and covers the endometrium. Elongation of the spiral ateries 
and glands occur, with the glands increasing significantly in number.  
The luteal/secretory phase: days 14-28 
LH surge at day 14 causes ovulation, the remaining follicle from which the egg was 
released becomes the corpus luteum and continues producing oestradiol and 
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relatively more progesterone. This stimulates to endometrium to become 
‘secretory’, and for the glands and stromal cells to enlarge (see Figure 2 below). The 
glands secrete a glycogen rich material. The endometrial stromal tissue can be 
observed becoming more oedematous (21). If fertilisation has not occurred by the 
end of this phase the corpus luteum fails thus leading to decreases in the steroid 
hormones, and menstruation ensues.  
 
 
Figure 2: Late-secretory phase endometrium, showing signs of enlargement of endometrial glands 
and oedematous areas. 
 
Decidualisation 
Decidualisation is essential for implantation to take place. The endometrium 
undergoes a series of changes in order to maximise the receptivity of the uterus to 
the conceptus. 
 
Stromal Cells: 
These cells increase significantly in size (5 fold) and change from spindle-shaped to 
fleshy decidual cells (22). These cells lay down a matrix of peri-cellular rim of 
extracellular matrix proteins (ECM), (laminin and fibronectin) (22). They also 
increase production of various proteins, including prolactin, renin and insulin-like 
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growth factor binding protein-1 (IGFBP-1) (22). Although the function of the 
prolactin and renin are poorly understood, it is thought that IGFBP-1 with the matrix 
serves as a scaffold for trophoblastic cells to invade (22). IGFBP-1 and firbonectin 
contain RGD (arginine-glycine-aspartic acid) sequences that have the ability to bind 
to α5β1 integrins expressed by extravillous trophoblastc cells (23). The secretion of 
these cells is maintained by progesterone (24). 
 
Spiral Arteries: 
These arteries modify in a way unique to the endometrium, it does not involve 
capillary sprouts degrading the basement membrane and migrating into 
surrounding connective tissue (25). The integral structure of the artery is 
maintained while it grows and increases in length (26). During placentation walls of 
the arteries are destroyed and the lumen dilates (22).  
 
Endometrial Glands: 
After proliferating in the follicular phase, the glandular epithelium differentiates, 
allowing it to start secreting. Their secretary ability is maximal through days LH+5 to 
LH+7 (22). 
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1.3. Recurrent Implantation Failure  
IVF has improved over the past two decades, however its success rates have 
remained fairly constant, and remain relatively low, the latest figures show of all IVF 
attempts only 23.1% are successful and result in a live birth (7). Many couples are 
left childless even after several cycles of IVF. The burden on the couples involved, 
psychologically and financially is great, with state funding available on a limited 
basis. 
This clinical dilemma leads patients to seek alternative treatment, where evidence 
base is lacking to prove their efficacy or safety (27). These can range from 
pregenetic screening, assisted hatching, blastocyst culture, allogenic culture, GIFT or 
ZIFT or immunosuppression. 
Recurrent implantation failure (RIF) is the failure of implantation of the embryo into 
the uterine wall following embryo transfer in an IVF cycle. The ‘recurrent’ element is 
usually defined as three failed IVF cycles, however this varies amongst literature 
and studies undertaken have often limited this definition to at least two IVF failed 
IVF (28). It is important to distinguish the difference between these two definitions. 
Studies following the success of subsequent IVF cycles have found that the likely 
success of conceiving from IVF remains constant in the first three cycles, however, 
chances decline thereafter (29-34). 
Another popular definition of RIF states that it is the failure of conception following 
the transfer of 10 ‘good quality’ embryos (35-38). What defines a ‘good quality’ 
embryo is subjective, and for those under 40 who would have had only two 
embryos transferred at each cycle, this would result in a total of 5 failed cycles 
before falling into this category, equating to much time and even more expense for 
the couple.  
One must also consider the nature of the cycle. Fresh versus frozen embryo 
transfer. Live birth rate (LBR) has increased steadily over the past fifteen years and 
is currently around 20% for frozen embryo transfer (7) (5% higher with donated 
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embryos) and it is higher with fresh cycles 27.5% in 2006 (7) higher with donated 
sperm. 
The proportion of patients using cryothawed embryos has increased (7,28), this is 
probably in part due to the limitation on the number of embryos allowed for 
transfer in one cycle and the enhances in ovarian stimulation and embryo 
cryopreservation protocols. 
Another point that needs considering is at what point is the best time to transfer 
embryos back into the uterus, at days 3, 5, or blastocyst stage. Various studies have 
been conducted to investigate the ideal day to transfer. Cruz et al.(39) conducted a 
retrospective trial comparing 15 IVF cycles with blastocyst transfer (days 5/6) and 
22 cycles transferred at day 3, with patients having completed 4 cycles of IVF 
previously. They reported increases in implantation and pregnancy rates with 
blastocyst transfer, however, this is a very small number of cycles, in this 
retrospective study. In a larger, prospective study by Simon C et al. (40), looking at 2 
day transfer versus blastocyst transfer, 168 patients underwent blastocyst transfer. 
Implantation and pregnancy rates (11.9% and 20.2%) compared to just 20 patients 
undergoing 2 day transfer implantation and pregnancy rates 10.7% and 35% 
respectively. The authors state these results were comparable to each other, 
reinforcing that stage of embryo transfer is not the main factor in patients with 
recurrent implantation failure.  
Also what constitutes implantation failure, at what point after embryo transfer is it 
considered a failed implantation? Is it the lack of a positive pregnancy test at two 
week post transfer, or the lack of a visible gestational sac at five weeks or the 
absence of a foetal heartbeat? With different definitions, how can one be sure it is 
true implantation failure or ‘biochemical loss’, which may indeed have a completely 
different aetiology. 
Hence infertility, in particular, recurrent implantation failure is a multifactorial 
disease in which an inhospitable uterine environment might significantly exacerbate 
the problem. 
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1.3.1 Overview of fertilisation and implantation.  
Dissolution of the zona pellucida indicates the blastocyst is ready to implant (see 
Figure 3 below). When the blastocyst attaches to the endometrium in the secretory 
phase, it orientates itself so that the inner cell mass is facing the endometrium. The 
endometrial glands in this area then enlarge and the tissue becomes more 
vascularised, subsequently the blastocyst firmly implants into and is surrounded by 
the endometrium (5). 
The zona pellucida acts as a barrier to immunological attack, between the mother 
and embryo, as it lacks histocompatibility (human leukocyte antigens – HLA). It also 
aims to prevent premature implantation of blastocyst into the fallopian tubes, as 
implantation cannot occur until the blastocyst ‘hatches’ from this ‘shell’ (5). This 
process initiates pre-implantation signalling, changing the structure of the uterus 
and promote orientation of the blastocyst to implantation site (41).  
Stages in implantation (42)  
Apposition: 
Apposition can only occur during the ‘implantation window’, because it is 
associated with maturation of the endometrium. It is the very first (loose) contact of 
the blastocyst with the endometrium (43). 
Adhesion: 
The apical surfaces of endometrial epithelial cells express adhesion molecules (such 
as integrins) that allow implantation to take place. Similarly, trophoblastic cells of 
the pre-implantation blastocyst also express adhesion molecules at their surfaces. 
Protrusion of the trophoblast, microvilli, interact through cell surface glycoproteins, 
with the epithelial lining of the uterus. This stage produces a much stronger 
connection than that in apposition (8,41). The blastocyst attaches to the 
endometrial epithelium through the mediation of bridging ligands. This is termed 
adhesion. Studies (in vivo and in vitro) have shown that the attachment of the 
blastocyst to the uterine wall occurs after the rotation of the blastocyst, so that 
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attachment occurs at the embryonic pole. If the attachment site is so specific, it 
may be that the surface of the blastocyst differs in expression of surface adhesion 
molecules. 
Penetration:  
Next stage is termed ‘penetration’ and involves the penetration of the blastocyst 
into the uterine epithelium. The trophoblast differentiates into two distinct cell 
types; syncytiotrophoblast and cytotrophoblast. Small projections of 
syncytiotrophblastic cell mass invades between uterine epithelial cells, through the 
basal lamina, and into the endometrial stroma. This invades into the uterine mucosa 
to induce a decidual reaction. This stimulates the stromal cells to enlarge and 
become filed with glycogen thus providing nourishment to developing embryo. (44) 
Trophoblastic Invasion: 
This is the accumulation of the above stages, with resultant embedding of the embryo 
completely into the uterine wall, it becomes surrounded by syncytiotrophoblast cells. Lytic 
activity of the syncytiotrophoblast leads to development of lacunae and subsequent 
placental development with maternal blood flowing through vessels and lacunae to the 
foetus (41). 
 
 
 
 
 
 
 
 
Figure 3: The change in structure and development of the blastocyst in the first few days from 
fertilisation (adapted from Essential Reproduction(21)) 
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Pinopodes and Implantation 
Pinopodes are small, finger like projections from the endometrial surface, thought 
to have a key role in the adhesion of the blastocyst to the endometrial surface. They 
appear between days 19 and 21 of the menstrual cycle, some suggest (45) that they 
are a marker of endometrial receptivity (45). They have a short-life span and appear 
for approximately 2-3 days. Their development is enhanced by progesterone and 
inhibited by oestrogens (45). They endocytose uterine fluid and consequently bring 
the uterine walls closer to the embryo by decreasing volume of the uterine cavity.  
 
If it was shown that pinopodes appeared earlier in stimulated cycles it would 
indicate a shorter ‘window of implantation’ in these women than controls and may 
possibly explain the problems with implantation. Nikas et al.(46) found that 
pinopodes do not appear to be affected by ovarian stimulated cycles in patients 
undergoing IVF treatment, with their numbers, morphology and life span appearing 
similar between these patients and controls (47). However they did find that 
pinopodes appear at slightly different stages in the cycle, appearing earlier in 
women in stimulated cycles by a day or two. Whereas I. Oborna et al.(48) found 
that pinopodes did not vary in timing under hormonal preparation of the 
endometrium. The differences in results could be explained by different timings of 
biopsies and different hormonal concentrations. However Quinn et al.(45) have 
shown that they are not useful in the mouse or human models as consistent 
markers of endometrial receptivity for implantation. In the human, pinopodes have 
a prolonged (>5 days) presence in the luteal phase and fail to delineate the brief 
(24-48 h) window of receptivity 
 
The failure of the embryo to implant is thought to be responsible for 75% of 
conceptuses lost (49). Mechanisms that can lead to this are either within the 
conceptus or the uterus. Chromosomal abnormality is estimated at occurring in 60% 
of conceptuses, if three fertilised oocytes are transferred into the uterus, it gives 
the chance of 78% of having a normal conceptus (50), when you compare this to the 
27.9% success rate for IVF, it is more suggestive that the problem lies within the 
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uterus. Factors affecting implantation in the uterus are related to structural and 
hormonal irregularity. Immune factors within the endometrium has gained 
significant attention for many years (51).  
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1.4: Immune System Overview  
The innate immune system acts as the body’s first line of defence against hostile 
agents, acting in a non-specific nature against foreign bodies. There are four major 
functions of the innate immune system, they are: 
 Recruiting immune cells to sites of infection and inflammation via cytokines 
 Initiation of the complement cascade 
 Phagocytosis of foreign body material through recognition of self from non-
self 
 Antigen presentation leading to activation of the adaptive immune system 
The innate immune system consists of leukocytes (see Figure 4 below), derived 
from pluripotent haematopeoitic stem cells in the bone marrow. The leukocyte 
population consists of the following cells: Mast Cells, Eosinophils, Natural Killer 
Cells, Phagocytic Cells (macrophages, neutrophils and dendritic cells) (52). The main 
type of cells active in the innate immune system are neutrophils, consisting of 50 – 
60% of circulating leukocytes, they are phagocytic in nature, engulfing foreign 
pathogens, they are classified as granulocytes due to cytoplasmic granules, which 
contain toxic substances to pathogens.  
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Figure 4: Leukocytes cell lineage. Adapted from CHXA: Leucocytes. (53) 
Natural killer cells recognise, attack and kill cells that have been infected with 
intracellular pathogens. They do not have antigen receptors, unlike B and T cells, 
but instead recognise phenotypical changes in target cells (54). The decision to kill is 
based on the balance of signals from inhibiting and activating receptors (53), such 
as Killer Inhibitory Receptors (KIRs) and NKG2D, an activating receptor(54). KIRs 
recognise MHC (major histocompatibility complexes), tumour cells, for example, 
lose MHC class 1 and thus KIRs are not activated and so NK cells are not inhibited 
and thus attack these cells. DNA damage and infection triggers NKG2D and activates 
NK cells(55). 
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1.4.1 Uterine Leukocytes 
The stratum basilis contains lymphoid aggregate, consisting of T cells. B cells are 
very minimal and almost absent. In the proliferative phase, the stratum functionalis 
contains few uNK cells, T cells and macrophages, with macrophages increasing in 
number prior to menstruation(22). There is also a signifcant number of 
macrophages found at the implantation site (22) 
Decidualisation, induced by progesterone, is associated with a rise in the number of 
leukocytes to the endometrium. 70% of the CD45+ leukocytes are CD56bright NK 
cells, together with some macrophages and a small number of T cells. B Cells are 
very minimal and are almost completely absent. 
Recently IL-15 and prolactin have been implicated in the proliferation and 
differentiation of these cells. Both of these hormones are produced by the stromal 
cells of the endometrium and their production is upregulated in the presence of 
progesterone (56). 
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1.4.2 Implantation and the immune system 
Cytokines and the endometrium 
During the ‘window of implantation’ there must be an appropriate balance of 
several factors that influence blastocysts adhesion in the endometrium. These 
factors involve the communication between hormones; paracrine and endocrine, 
adhesion molecules and cytokines (18). The interaction between these factors must 
be at its maximal during this period. Subsequent to this period the endometrial 
stroma undergoes ‘decidualisation’; fibroblastic stromal cells differentiate into 
secretory decidual cells, this is associated with increased production of proteins. 
Some of which are insulin-like growth factor binding protein and prolactin. 
Cytokines are produced by the immune cells.  There are three types of these cells, 
all producing differing cytokines with varied function. See table below (18,57,58): 
Table 1: Cytokines produced by various cell types and their function 
Cell Type  Cytokines Produced Effect 
Th1 Inteferon Gamma (IFNγ) Tumour necrosis 
factor β (TNFβ),   
Interleukin 2 (IL-2) 
Cell mediated 
Immune Responses 
Th2 Interleukin – 4 (IL-4) 
Interleukin – 5 (IL-5) 
Interleukin – 6 (IL-6) 
Interleukin – 10 (IL-10) 
Antibody mediated 
humoural responses 
Th0 Can be converted into either Th1 or Th2 
and can produce each of the above 
respective to each cell as well as: 
Tumour necrosis factor α (TNF α) 
Granulocyte-macrophage colony-
stimulating factor (GM-CSF)  
 
Macrophage Interleukin 1 (IL-1) 
Interleukin 6 (IL-6) 
Pro-Inflammatory 
cytokines 
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TNF α 
Leukaemia inhibitory factor (LIF) 
Uterine Natural 
Killer Cells 
Colony-Stimulating Factor 1 (CSF-1) 
TNFα, IFNγ, IL-1α, Transforming Growth 
factor β (TGFβ), LIF and GM-CSF, 
angiogenic cytokines-VEGF C 
 
 
As well as the above mentioned cells, it has been discovered that non-immune cells 
within the endometrium, can secrete these cytokines. These cells are active in the 
pregnant and non-pregnant uterus. It has been suggested, through 
immunocytochemical studies that epithelial cells are responsible for a large portion 
of the cytokines produced (59,60). After decidualisation uNK cells secrete a vast 
array of cytokines (see table above), suggesting that these cytokines are produced 
for the establishment of the blastocyst-endometrial connection. 
Several studies have investigated the interplay of Th1 and Th2 cytokines, looking at 
the balance between production and how this profile leads to a favourable 
pregnancy outcome.  
Rodent Population: 
Studies in rodents nearly fifteen years ago indicated that for a successful pregnancy 
the balance of production would be toward Th2 cytokines, with Th1 cytokines being 
harmful to a successful outcome (61). Similar studies in rodents focused on matings 
between abortion-prone and abortion non-prone mice (62), showed increases in 
TNFα, IFNγ, IL-2 when challenged in abortion prone mice, compared to abortion 
non-prone mice (63). Further to this, administration of these specific cytokines 
made the non-abortion prone mice more susceptible to abortion, and conversely 
administration of the Th2 cytokine, IL-10, decreased abortion tendencies in the 
abortion-prone mice (64,65).  
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Human Population: 
During pregnancy diseases with Th1 response decrease in severity, such as 
rheumatoid arthritis and conversely, diseases with a Th2 response increase, such as 
systemic lupus erythematosus. Studies investigating concentration of these 
cytokines in peripheral blood of recurrent miscarriage patients have yielded mixed 
results, one suggestion for these discrepancies is the timing of the blood sampling 
and whether they were taken in the absence or presence of miscarriage. Bates et 
al.(66) showed increased Th2 cytokines, IL-4 and IL-10, and decreased TNFα and Th1 
cytokines IFNγ from women with recurrent miscarriage, when compared with 
controls, samples were taken in early pregnancy. This is the opposite from what we 
would have expected, when using previous rodent data. 
When looking at the implantation failure population, Ginsburg et al.(67), increased 
IL-10 was observed in controls when compared to those with unexplained infertility. 
Kwak-Kim et al.(68) showed increases in the ratios of TNFα/IL-4 and TNFα/IL-10 in 
patients with RIF. However, excluding this, other studies have shown conflicting 
results with regard to IFNγ and IVF failures and TNFα. (67,69). Problems with 
defining the population and timing of blood sampling could explain difference in 
results.  
No studies investigating the profile of Th1 or Th2 cytokines within the endometrium 
of patients with implantation failure have been conducted.  
Lim et al.(70) and Shimada et al.(71) showed conflicting results in recurrent 
miscarriage patients, this can be explained by the difference in tissue analysis. 
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Interleukins: 
Table 2: Interleukins and their role in implantation. 
Interleukin Role in Implantation Study 
IL-1: 
 
 
 
IL-Ra 
 
Follicular Fluid: Increased 
IL-1α and IL-1β  
 
Low plasma IL-Ra and 
High plasma IL-1β 
 
Increased production of 
metalloprotineases and 
integrins, possible role in 
implantation. 
Prevents blastocyst 
implantation 
Correlated with successful 
IVF pregnancy 
 
Association between good 
quality embryos and 
clinical pregnancies 
 
Meisser et al. (72) 
Simon et al. 1997 (73) 
 
Simon et al. 1994 (74) 
 
Karagouni et al.(75)  
 
 
Spandorfer et al. (76) 
IL-18 (pro-inflammatory, 
Th1 response via IFNγ) 
 
 
 
 
IL-18 decreased in mice 
placenta from abortion 
prone mice 
 
Abnormal expression in 
implantation failure 
patients, varying degree 
of expression in epithelial 
and stromal areas 
Chaouat et al. (77) 
 
 
 
Ledee-Bataille et al. (78) 
IL-12 (pro-inflammatory, 
Th1 activation) 
Increased expression in 
10/35 IVF implantation 
failure patients  
Ledee-Bataille et al. (78) 
 
These studies are heterogeneic in nature and consequently a direct comparison of 
results is difficult. Ideally studies investigating this area should clearly define study 
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population with confounding variables accounted for, in detailed clinical history, for 
example, cause of infertility, number of cycles previously attempted and number of 
embryos transferred, whether ‘good quality’ embryos were replaced. Another 
factor to consider is which cells were investigated, as mentioned earlier cytokines 
are not only produced by immune cells, and a comprehensive look at production 
profile in a well-defined population Is needed. 
It has been shown that uNK cells are capable of producing cytokines (18,57,58), it 
has also been shown that these cells have receptors for some cytokines, IL-1, IL-2, 
TNFα (57,79). IL-2 expression, in vitro on uNK cells has been shown to increase the 
expression of CD16 on uNK cells (80). It also has been shown to induce cytotoxicity 
towards the trophoblast (81). 
Receptors for cytokines are present on decidual cells as well as trophoblastic cells 
(18). The interplay between these cells and uNK cells may well directly impact on 
the outcome of implantation through the direct and indirect action of cytokines. 
 
LIF and implantation  
Leukaemia Inhibitory factor (LIF) has been shown to be influential in the 
implantation of blastocysts in animal studies (82). Its expression on glandular 
epithelium is induced by oestrogen before implantation occurs. It is said to peak 
during the mid-late secretary phase of the menstrual cycle (83)  and is secreted 
mainly by the glandular epithelium (84,85), and is not dependent on the presence 
of an embryo. 
Animals lacking LIF gene fail to implant their blastocysts into the endometrium wall, 
and when injected with recombinant LIF, implantation is restored (86). 
LIF is thought to work in a paracrine manner via the luminal endometrial epithelial 
cells, to prime the endometrium for reception of the blastocyst (87,88). 
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However in human studies the evidence is conflicting. There have been reports of a 
decrease of LIF detected in uterine flushings (83,89). Whereas others report no 
difference in infertile patients when compared to controls (90,91). 
There is supporting evidence for a role of LIF in implantation in animals, however 
more research needs to be conducted to establish a conclusive role for LIF in human 
endometrial implantation. 
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1.5. Natural Killer cells 
1.5.1 Uterine Natural Killer Cells 
1.5.1.1 History and terminology 
Presence of granulated cells in the endometrium is not a new discovery. Since as 
early as 1921 (92) the presence of these cells has been recognised. The presence of 
these cells was not restricted to human endometrium. Endometrium of mouse and 
rat also showed these cells (93). 
A stromal origin for these cells was generally the accepted even though there were 
suggestions by some scientists that the origin of these cells were in fact lymphocytic 
(human (92), mouse (94), monkey (95) ). In 1980s it was found that these cells 
stained positively for the CD45, the leukocyte common antigen (96) and later CD56, 
which confirmed the NK cell phenotype (97). 
Natural killer cells are a type of cytotoxic lymphocyte, approximately 15m, with a 
reniform nucleus (22), they can be distinguished from CD8+ T cells by their lack of 
rearrangement of T-Cell receptor genes. They are large lymphocytes that have an 
abundant granule-containing cytoplasm (large granular lymphocytes (LGL), they 
function by cell killing or cytokine production which is enhanced by cytokines 
mentioned earlier.  
1.5.1.2 Anatomy of placentation.    
Our innate immune system works to achieve the goal of defending itself from 
invading foreign bodies. What happens when a semi-allogenic foetus attempts to 
invade into the endometrium, having initiated decidualisation and is rapidly filling 
with lymphocytes? A symbiosis must exist between the maternal endometrium and 
the invading foetal trophoblast. A balance between these two must form to prevent 
extensive invasion (parasitism), limited invasion (pre-eclampsia) or outright 
rejection of this semi-allogenic being from the mother (implantation failure or 
miscarriage). 
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1.5.1.3. Location 
NK cells tempero-spatial relationship within the endometrium was also noted 
around the 1960s (98-100). It was noted that these cells occurred mainly in the late 
secretary phase and were visible in early pregnancy, as well as towards the end of 
pregnancy. These cells are thought to continue to a peak in pregnancy and then 
decrease in numbers by 20 weeks gestation and are absent in term decidua (see 
Figure 5 below) (101-104). They still feature in the proliferative phase and early 
secretary phase but in relatively small numbers (105,106). 
The relationship between gestational age and uNK numbers have been investigated 
with results from one study shown below (93), however a limitation of only 35 
patients means it is hard to accurately suggest differences between trimesters.  
 
 
Figure 5. Relationship between uNK cell numbers detected by phloxine tartrazine staining in decidua basalis and 
gestational age. Cells were counted in 5 × 400 fields of the central part of the placental bed in pregnancy 
hysterectomy samples (n = 35). (Copied with permission from Bulmer and Lash (93)) 
 
It is difficult to quantify the presence of NK cells in placental tissue in varying 
gestational age as there are confounding variables and the heterogeneity of 
samples. A factor is the way in which the biopsy was obtained, miscarriage and 
terminations will inevitably lead to a local inflammatory response, how soon after 
the event were the samples taken and then processed? Also placental bed biopsies 
will differ from complete hysterectomy samples as there may be less inflammation 
in a hysterectomy sample. Additionally we need to look at causality of miscarriage, 
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whether idiopathic and otherwise ‘normal pregnancies’ or pathology such as 
chromosomal abnormality. 
1.5.2 Peripheral Blood Natural Killer Cells 
Peripheral blood natural killer cells are distinctly phenotypically and functionally 
different from uterine natural killer cells. uNK cells for example exhibit low levels of 
cytotoxicity and cytolytic behaviour, most uNK cells are CD56+ and CD16-, whereas 
only 10% of pbNK cells stain this way with 90% of pbNK cells staining positive for 
CD16. 
It is necessary to determine the origins of these immune cells, how do they come to 
exist in such high numbers within endometrial tissue, fluctuating at different times 
in the cycle? The big question is testing the theory between peripheral blood origins 
and proliferation of locally derived uNK cells. The outcome is one which will affect 
clinical practice. Currently there are many clinicians who believe that ‘high’ 
numbers of uNK cells are a prognostic indicator and negative influential factor to 
implantation outcome. Subsequently various methods of reducing NK cell levels in 
the blood have been implemented in some of these patients. The scientific data 
behind the link between peripheral blood natural killer cells and implantation 
failure is differing, with opposing thoughts on the impact of these blood cells on the 
endometrium and implantation.   
It is important to look at the distinct differences in the phenotype and function of 
peripheral blood NK cells and uNK cells. 
The majority of peripheral blood NK cells are CD56dim and CD16+. CD16 is a low-
affinity receptor for IgG complex and is the receptor responsible for NK-mediated, 
antibody-dependant cellular cytotoxicity.  
Unlike uNK cells peripheral blood NK cells do not vary in number and activity in the 
menstrual cycle. However in pregnancy their numbers and functional ability have 
been found to be suppressed during pregnancy (107,108). 
The Origin and Role of uNK Cells In Patients With RIF                                                  Leena Khan 
 
31 
 
Koopman et al.(109) investigated the phenotype of these two populations, 
peripheral blood CD56brightCD16+ and CD56brightCD16- uNK cells, and have concluded 
that they are phenotypically different. Using microarray analysis, flow-cytometric 
and RT-PCR studies to obtain results. This suggests that peripheral blood NK cells 
are not uNK cells and must either differentiate to become these cells or are from a 
small, distinct population of peripheral blood NK cells. Consequently studies 
investigating solely peripheral blood NK cells are not reflecting the true picture of 
what is occurring at the feto-maternal interface. 
CD69 is one of the earliest cell surface activation markers expressed by NK cells. 
uNK cells also express a variety of KIR, killer inhibitory receptors, killing activating 
receptors (KARs) which recognise HLA-G expressed on extravillous trophoblast (80).  
NK cells do ‘kill’ trophoblastic tissue in vitro when first stimulated by the cytokine IL-
2, it is important to note however, that IL-2 is not present at the moment of 
implantation in the endometrial tissue (110).  
Differing results have emerged regarding reproductive outcome in mice studies 
within the same research group. Croy et al. has shown that in Terhost mutants NK 
cell deficient mice there is an increased rate of miscarriage. However this rate is not 
increased in IL-15-/- NK cell deficient mice (IL-15 is the activating cytokine for NK 
cells), similarly with IL-2 receptor knock-out mice, which also lack uNK cells (111). 
These differing results can be explained partly by the subset of NK cells that is 
affected by the knock-out mice.  
The relationship between peripheral blood NK cells and reproductive outcome after 
IVF or spontaneous pregnancy has been investigated in several studies. These 
studies however have been small-scale observational studies (50,112-117), The 
results from these studies show a connection between NK cell activity and 
subsequent implantation/conception failure or miscarriage. However, the reasons 
for reproductive failure in the patient populations were different (118). 
Methodological flaws within the studies centre around the sample and how it is 
obtained, whether whole blood samples or fractionated mononuclear cells used, 
the time of day in which the biopsy was taken, whether the patient had partaken in 
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physical exercise, stress, age of patient, sex and ethnicity (119) and whether 
samples were thawed from prior freezing (120-122). 
The level for ‘high’ peripheral blood NK levels, Beer et al.(113) was previously set a 
level of 12% of all lymphocytes, however other studies have a normal range as high 
as 29%. Eidukaite et al.(123) found that amongst normal healthy individuals the 
percentage of CD56+ NK cells in the blood can range from as little as 5% to as much 
as 29% (124). Therefore there can be a substantial crossover in of normal patients 
labelled as ‘abnormal’. 
The difference in measuring NK cell activity is also an issue. Most commonly the in 
vitro assay is cytotoxicity, however this may have little resemblance to what is 
taking place in vivo. 
Thum et al.(125) 2004, have shown an association with increases in absolute count 
of CD56DimCD16+CD69+ with implantation failure following IVF. It is important to 
highlight that that mean number of IVF failures in the sample population was 1.3, 
not enough to be considered ‘implantation failure’, there may not be pathology in 
patients who have only had one failed embryo transfer cycle. These cells were 
counted using flow cytometry, which is influenced by the variables mentioned 
earlier and the arbitrary nature in which the lymphocyte gate is set on the flow 
cytometer. The absolute count of CD56dimCD16+CD69+ is 1.66X106 this is out of an 
overall count for CD56dimCD16+ of 212x106 as a percentage, this proportion is 
merely 0.78%. This very small figure could contribute to a large margin of error. 
Looking at a ROC (receiver operating characteristic), the authors calculated an area 
under the graph as 0.63, with a perfect test having an area of 1 and a worthless test 
having an area of less than 0.5, a value of 0.63 does not infer that testing peripheral 
blood NK cells is of prognostic value in patients with implantation failure following 
IVF. 
Methods of clinical intervention in this patient population involve attempting to 
suppress an ‘excessive’ immune response and lower NK cell numbers and 
activation. Treatments include LIT, (lymphotcyte immunisation therapy); IV 
immunoglobulins, anti-TNF-alpha and gluccocorticoids. These interventions are 
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associated with significant side effects (126-129), and when rationale behind their 
use is incomplete, it is unsafe and unethical to subject patients to these unproven 
treatments.   
Fukui et al.(114) previously showed an increase in CD16+ NK peripheral  blood cells 
was associated with a failed implantation following IVF treatment. 
Fukui et al.(130) reported a significant difference in the cytokine profile in 
peripheral blood cells in a sample of patients with recurrent miscarriage and those 
with implantation failure, but no difference in the percentage of CD56+, CD56bright 
and CD56dim between these two groups and a set of controls (n=15). The only 
differences were in CD56bright/Interferon γ+/TNK-alpha+ and TNF alpha/GSM-CSF 
expressing CD56bright cell ratio in all three groups, with significant increases in the 
RM and implantation failure samples. However, sample numbers were small, n=20 
in each comparison group and implantation failure of only 4 embryo transfers was 
set as the inclusion criteria for implantation failure, this, as discussed above does 
not cover the general consensus on what defines implantation failure. Methods 
included were flow cytometry, analysing a fraction of the sample of isolated 
mononuclear cells from peripheral blood sample, with 3x104 cells analysed in each 
sample. 
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1.5.3 Recurrent Miscarriage (RM) 
Much focus and investigation into the subject of uNK cells, their interaction and role 
within the feto-maternal unit is centred in the pathology of recurrent miscarriage. 
Similar to implantation failure, RM patients have negative reproductive outcome, 
coupled with intense emotional turmoil for patients. These patients have managed 
to overcome the hurdle of conceiving and implantation of embryo firmly into the 
uterine wall. However, it is no less traumatic for the patients and families involved. 
Several studies have highlighted the importance of timing in endometrial sampling 
of these patients, and necessitate the accuracy of measuring the LH surge, to be 
sure to obtain samples in this narrow window (131).  
Several studies have investigated the prognostic value of NK cells in recurrent 
miscarriage.  
Quenby et al.(132) 1999 and Clifford et al. (133) showed an increase in number of 
CD56+ uNK cells in patients with RM in the non-pregnant endometrium, however 
Michimata et al.(134), were unable to show any difference between RM patient and 
controls. Quenby et al.(132) 1999, had a sample population of 12 patients, 4 of 
which went on to miscarry and 8 of which went on to have a live birth. It was shown 
that patients who went on to miscarry had significantly higher levels of uNK cells 
than the live birth patients. However Michimata et al.(134), in a study of 17 women, 
6 of whom miscarried, failed to show any difference. It is important to highlight that 
in the later study, the inclusion criteria included women with only two previous 
miscarriage, this does not conform to the widely excepted definition for this disease 
of three or more consecutive miscarriages. It could be that the differences in the 
finding can be explained by the more severe phenotype of patients in the previous 
study and the lack of appropriate patient selection in the later study. 
Both these studies had a small sample population, which hinders the ability to draw 
pertinent conclusions.  
As with studies in RIF, the ability to make comparisons between studies is made 
difficult by the heterogeneity of quantifying uNK cells. Clifford et al. 1999 (133) 
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opted to use the mean number of uNK cells, whereas Quenby et al.(132) 1999 and 
Tuckerman et al.(60)  chose to view these cells as a percentage of stromal cells, 
Michimata et al.(134), elected to quantify the proportion of uNK cells to 
CD45+leukocytes.  
Tuckerman et al. (135) 2007, investigated the prognostic value of uNK cells in 
patitents with RM, in 87 women with LH timed endometrial samples, paraffin 
embedded and counted numbers of CD56+, 51 of the women went on to become 
pregnant, of the 51 women, 32 proceeded to a live birth and the remainder, 19 
miscarried, with a control group of 10 patients, 7 with proven fertility. However, no 
description on how the cells were counted, or how stromal cells were counted to 
obtain a percentage. 
They found the means of CD56+ in the control group was 6.2% and significantly 
lower (p=0.013) than in the 87 women, 11.2% (CD56+ count), which is higher than 
observed by Quneby et al.(136) 2005, who stated a level of 5% based on the upper 
interquartile level of their control population (n=18). 
 
Tuckerman et al.(135)  2007 did not find any difference between the live birth 
group and the miscarriage group in terms of uNK levels. It is important to note that 
the levels in the live birth group varied from 1.1 – 41.4%, which is very large. 
Although this is a better powered study, one must question the accuracy of 
analysing the count of CD56+ compared to stromal cells in the high-powered fields. 
  
Quenby et al.(136) 2005, trialled the administration of prednisolone in women with 
RM, with aim to lower uNK cells and lead to a subsequent live birth in the next 
pregnancy in 85 women, with 18 sterile women as controls. Of the 85 women, 29 
with uNK levels (from endometrial biopsy at day 21 of menstrual cycle) >5% 
consented to take 20mg prednisolone daily from day 1 to 21 of their menstrual 
cycles. On this cycle, a second biopsy was taken. Women with RM were found to 
have significantly higher levels of uNK % than controls (p=0.008), with prednisolone 
reducing levels of uNK from a median of 14% (before) to 9% (after) (p=0.0004). This 
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study is the basis for a current randomised trial into the effects of prednisolone vs 
placebo on RM. 
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1.5.4. uNK cell Receptors 
By the late secretory phase NK cells proliferate to encompass 30% of endometrial 
stromal cells (119). They continue to increase in number and are found in high 
concentrations surrounding implantation sites (119). Hence they are in close 
proximity to the invading trophoblast and must therefore be in contact with them. 
The suggested function in vascular remodelling occurs here to modify spiral arteries 
to increase flow of blood across the feto-maternal interface via the placenta (119). 
The method of interaction between uNK cells and trophoblast tissues is unknown 
but receptors on uNK cells have been found corresponding to those on 
trophoblastic cells (80). Major histocompatability complexes (MHC) 1 molecules 
have been found to bind to receptors on NK cells. 
 
Activation/Inhibitory Markers 
 uNK cells express KIRs, killer-inhibitory receptors for HLA-G, which is uniquely 
expressed by invading trophoblastic cells (137) suggesting, strongly the association 
between these cells and facilitating the implantation of the trophoblast. 
uNK cells also express KIR for HLA-C, which is the most dominant and it is thought 
that this combined with specific polymorphisms for foetal HLA-C may lead to 
problems with trophoblast invasion (138,139). 
Negative control of cytolytic potential may exist in normal pregnancy as the HLA-E 
ligand of CD94/NKG2A is expressed by extravillous cytotrophoblast. 
CD69 is an early activation marker (140,141,141), present in the proliferative phase, 
decreasing through menstrual cycle. 
Natural cytotoxcicty receptors (NCRs) include NKp30, NKp44, and NKp46, 
responsible for NK cell activation resulting in cytokine production and/or target cell 
lysis (142)(143)(144). NCRs are part of the immunoglobulin superfamily and are 
pivotal to NK cell function (143). Vacca et al.(143) have reported the presence of 
NKp46 and NKp30 on resting and activated circulating NK cells. 
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NKp30 has been found on decidual NK cells (145,146) but their presence on uNK 
cells has been reported with conflicting results.  
El Costa et al.(147) showed that activating receptor engagement of NKp30, induces 
the production of several key pro-inflammatory cytokines IFN-γ, TNFα, MIP-1α and 
GM-CSF, in vitro on decidual natural killer cells, with dose effect. These effects 
decreased by addition of NKG2A (p<0.0031). They also showed cytolytic activity 
induced by engagement of NKp46, effects of which were blocked by NKG2A.  
Manaster et al. (148), investigated the occurrence of NKp30 receptor on uNK cells in 
the non-pregnant uterus. They found a lack of expression of NKp30 prior to 
activation of IL-15 and conclude that these NK cells are ‘immature cells’ that await 
pregnancy. Unfortunately there are many flaws with this data. Firstly the patients 
that were sampled, 25 women, had cycle status confirmed on ultrasound and blood 
progesterone levels, neither of which are as reliable as the narrow peak of the LH 
surge. Secondly flow cytometric analysis was used, which one cannot assume was 
free from any stromal or peripheral blood NK cells in the isolation of uNK cells. They 
showed presence of NKp46 across each phase, little NKp44, and flow graphs 
produced show a very slight increase in NKp30. 
This study did however, show a substantial presence of NKp30 ligands on 
endometrial stromal cells. 
Ponnampalam et al. (149), also studied NKp30, using immunohistochemistry, and 
found staining of endometrial epithelium with NKp30, however this was performed 
on frozen sections. NKp30 mRNA was increased in fresh cultured tissue from the 
late secretary phase 
IL-15 has been shown to be necessary for the differentiation of uNK cells in mice 
(150). uNK cells have also been found absent from the implantation sites of mice 
deficient in IL-15 and subsequently had no evidence of spiral artery modification 
(151). IL-15 also activates uNK cells to lyse classical NK cell targets in vitro (93). IL-15 
levels are higher in the secretary phase, than the proliferative phase endometrium 
(152) and endometrial stromal fibroblasts have been stimulated to produce it by 
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progesterone, in vitro (153). Ponnampalam et al. (149), also studied NKp30, using 
immunohistochemistry, and found staining of endometrial glandular epithelium 
with NKp30. 
 
Proliferation Markers 
A previous study investigating proliferation of uNK cells, using 
immunohistochemical staining in frozen sections found that 40% of CD56 positive 
uNK cells, in the late-secretary phase endometrium express the antigen Ki67 (154). 
 
Trafficking Markers 
L-Selectin 
The rise in LH and ovarian steroid stimulate the adhesive properties of natural killer 
cells to mouse uterine mucosa through the effect of L Selectin and α4-dependant 
mechanisms, it is still unclear whether these effects are direct or indirect 
(150,155,156). This support the hypothesis that NK cells are recruited from 
peripheral circulation, however this has been found in mouse, not human tissue. 
Human blastocysts utilise L – Selectin to help them adhere to the uterine wall by 
binding to uterine ligands, to initiate implantation. It is hypothesised that the 
absence of these ligands on the uterine wall could lead to recurrent implantation 
failure (157).  
A study (158) found that L-Selectin expression varied throughout the menstrual 
cycle. This expression was highest during ovulation and remained high through to 
the endometrial mid-secretory phase. This occurs at the same time as implantation 
therefore any defects in this adhesion mechanism of L-Selectin may explain why 
embryos fail to implant. 
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Steroid Receptors 
uNK cells have oestrogen receptor β, but not oestrogen receptor α (80,159). uNK 
cells vary in number and structure through the menstrual cycle. This is thought to 
be tightly linked to the levels of progesterone (93), as they increase rapidly in 
number after ovulation (137), which synchronises with the rise in progesterone, and 
the tailing off of oestrogen levels. As progesterone decreases, uNK cells apoptose 
(80) this is thought to indicate the first sign of menstruation rather than 
decidualisation and implantation. However uNK cells do not have progesterone 
receptors (159). It has been suggested that progesterone exerts its influence on uNK 
cells via the action of IL-15, which L-Selectin and α increases as progesterone 
increases (160). Progesterone receptors have been found on stromal cells (24) and 
stromal cells have been shown to produce IL-15 in the decidualising uterus in both 
humans and mice, A study (153,161,162) looked at in vitro addition of sex 
hormones to isolated and highly purified CD56brightCD16- on proliferation, 
cytolytic behaviour and cytokine production in 7 terminations of pregnancy 
specimens and 13 histologically normal hysterectomy specimens. They found that 
activity of NK cells were not directly influenced by progesterone or 17β-oestradiol. 
However this study was carried out in vitro and may not be a true reflection of in 
vivo circumstances.  
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To evaluate the function and origin of these cells it is necessary to look at the 
following markers (80,93,148,154): 
Table 3: Markers to be used in determining distribution and function of uNK cells. 
 
Marker Reasons for Investigation 
CD56 This is the universal marker for NK cell and will identify 
which cells are uNK cells so we can observe the variance in 
location and staining patterns. 
CD16 Maker for the majority of peripheral blood NK cells, will 
identify which cell are likely to be coming from peripheral 
blood into the uterus 
CD62-L / L-Selectin A migration marker for leukocytes. If present in the 
endometrium signals that NK cells have arisen through 
trafficking of peripheral blood NK cells into the 
endometrium. 
Ki67 A nuclear marker for proliferating cells. This, with location 
variance might indicate the potential role of NK cells. 
NKp30 A novel marker for activation of NK cells. This, with location 
variance might indicate the potential role of NK cells. 
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1.5.5 Theories of Origin of uNK Cells 
There has been much speculation surrounding the origin of these cells. Two main 
competing theories have arisen, these are: 
 uNK cells arise from the trafficking of peripheral blood NK cells into the 
human endometrium. 
 uNK cells arise from the proliferation and differentiation of resident NK cells 
already within the uterus. 
 
1.5.5.1 Trafficking: 
Substantial work carried out by Croy and colleagues have focused on trying to find 
evidence to support this theory, with the majority of work done in rodent and 
porcine models (151,155,156). They have found that endometrium becomes ‘sticky’ 
to NK cells from the blood when the homing marker ‘L-Selectin’ is present (163). 
The concept is this, leukocyte express adhesion molecules, such as L-Selectin, and 
once activated by the engagement of a chemokine receptor, they are subsequently 
able to attach to their ligands, expressed on the endothelium(164). This was 
investigated using an adapted Stamper-Woodruff adhesion assay (165) using mouse 
uterus, attaching various other tissues to it, including human endometrium. They 
were successful in finding an adhesion between these two tissues but this 
depended heavily on the presence of L-Selectin and alpha-4 integrin, so much so 
that if the receptors for these molecules were blocked the adhesion was eliminated 
(163)(163). Subsequent study in IVF patients showed that in sampling peripheral 
blood lymphocytes their adhesion was irrespective and unaltered by administration 
of exogenous hormones or establishment of pregnancy comparative to menstrual 
cycle (166). However an increase in adhesion by LH +40 was shown to be apparent 
in those with sustained pregnancy compared to those without, indicating that there 
may be a link between uNK cells secreting molecules aiding implantation.   
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Figure 6: Diagrammatic representation of the process of lymphocyte migration.  
Adapted from Kitaya et al.(152) 
 
Studies (167-169) have shown that selectin adhesion systems mediate the initial 
interactions between leukocytes and vascular endothelial cells (see Figure 6 above). 
These adhesion systems allow leukocytes to adhere strongly to endothelial wall, 
against the flow of blood. 
Van Den Heuvel (170) also found that in fertile women an increase in L-Selectin 
(CD62-L) occurs between CD56+ cells and the endothelium around LH surge. They 
further conclude that this recruitment of peripheral blood NK cells to the 
endometrium occurs with increases in oestrogen and LH and is limited by increases 
in progesterone. In the murine model pro-uNK cells (self-renewing progenitors to 
uNK cells) are developed from pre-uNK cells from peripheral lymphoid sites (155). 
These cells are thought to get to the decidua via the vessels. Once in the 
endometrium it is thought that these uNK cells then undergo proliferation (as seen 
by mitotic figures) and differentiation. NK cells are not solely recruited by the 
conceptus, as they have been found in conceptus-free decidua (171,172) However it 
is thought that these cells need the conceptus for sustainability, as without this they 
show signs of senescence towards end of cycle (173). 
Work in porcine endometrium is also supports the concept of trafficking of NK cells 
from the blood into the decidua (174), however this model uses a completely 
different form of placentation, involving development of subepithelial capillary 
plexus, completely non-invasive, contrastingly different to the human placenta.  
Lymphocytes 
Tethering -Rolling 
Activation Tight Adhesion 
Transendothelial 
migration 
L-Selectin Integrin 
α1β2 
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Differentiation of these uNK cells, in mice is stimulated by IL-15, and mice lacking 
this interleukin have found to be unable to differentiate their NK cells and as such 
their arteries resemble those that cannot be modified (175).  
There is much evidence regarding the role and function the uNK cells in spiral artery 
modification and their concentration near vascular structures supports this concept 
presence near vascular structures. 
Conclusively, the work above has been undertaken primarily in murine models and 
the adhesion factor driving the theory of trafficking depends heavily on the 
presence of specific adhesion molecules.  
 
 
1.5.5.2 Proliferation 
The presence of NK cells in the human endometrium peaks in the late-secretory 
phase (176). Though there are only a few CD56Bright cells in the proliferative phase 
they are still present, it could be that these cells are the remnants from the previous 
cycle, as the stratum basalis is not shed during menstruation (176). 
Mitotic figures are seen and are a recognised feature of premenstrual 
endometrium. There is an increase in the number of Ki67 (40% based on 
immunohistochemistry on frozen sections (177)) present in the secretary phase 
endometrium and deciduas of early pregnancy which supports this theory. 
Maximum proliferation was also observed in secretary phase endometrium with 
decreasing numbers with increased gestational age (178).  
There are a limited number of CD16+ cells observed in endometrium, at any point in 
the menstrual cycle. If these CD16+ cells were indeed trafficking from the peripheral 
blood would there not be increased number of CD16+ (90% of peripheral blood NK 
cells) cells in the endometrium?  The fact that these are lacking would push towards 
a theory of proliferation of the abundant CD56brightCD16- NK cells in the 
endometrium. Trafficking supporters may postulate that the peripheral blood NK 
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cells undergo modification under the uterine microenvironment, in which they 
subsequently resemble the majority of uNK cells. 
Alternatively the rise of CD56BrightCD16- uNK cells could be solely the end result of 
recruitment of this minute population of peripheral blood NK cells and there 
subsequent proliferation and differentiation of the more prevalent  CD16- into the 
common uNK cell. 
The concentration of IL-15 which stimulates proliferation of uNK cells peaks during 
the secretory phase (179)  at the time when uNK cells density is at its highest. 
If indeed these cells are arising from the proliferation of resident uNK cells they 
could possibly be coming from bone marrow, Taylor (180), found that in 4 women 
with HLA mismatched bone marrow transplantation, donar HLA-phenotypes were 
discovered in these women’s endometrium, as glandular and stromal cells. 
Indication that these stem cells can migrate to the uterus and form cells there. 
There could also be resident haematopoietic ‘stem cells’ within the endometrium, 
form which uNK form and proliferate (152).  
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1.5.6 uNK cell function 
1.5.6.1 Vascular Function 
uNK cells tend to localise near blood vessels(181), whether this is because they are 
recruited from peripheral blood via these vessels or they congregate around the 
vessels having developed from proliferating resident uNK cells. The link between 
uNK cells and vessels is further highlighted with the decrease of uNK cells around 20 
weeks gestation where vascular remodelling is complete. 
Studies in mice(151) have highlighted  the importance of uNK and their functional 
role in the establishment of spiral arteries. Modification of these arteries is essential 
in the formation of the human placenta. It allows the necessary transfer of nutrients 
between mother and foetus. Failing to establish good arterial flow from mother to 
foetus can result in complications for the mother e.g. pre-eclampsia, and 
complications for the foetus, IUGR and miscarriage. uNK cells have been found to 
produce a number of key angiogenic factors such as VEGF-C, placental growth 
factor, angiopoeitin 1 and 2 and transforming growth factor β (131,181,182) in the 
non-pregnant uterus as well as in early pregnancy decidua.  
Angiopoeitin is only expressed by those tissues with vessels undergoing 
remodelling, therefore it may be a important mediator for spiral artery 
transformation. 
Hiby et al. (183) compared the genotypes of maternal uNK cell in patients with and 
without pre-eclampsia, they found that patients with the genotypes that were 
inhibitory on uNK cells had higher rates of pre-eclampsia. This would suggest that 
uNK cells that are maximally inhibited allow trophoblast to prematurely cease 
remodelling of spiral arteries pre-disposing to pre-eclampsia. 
Inteferon γ, produced by uNK cells is also is thought to play a role in artery 
modification as shown in mice studies, where those mice deficient in either this 
cytokine of uNK cells had abnormalities in implantation site and lack of decidual 
artery transformation. 
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A recent study conducted by Qeunby et al. 2009 (181), showed an association 
between uNK cell density and the formation of blood vessels, lymphatics, spiral 
artery smooth muscle differentiation and endometrial oedema. Additionally 
increased density of uNK cells associated with a clinically reduced uterine artery 
resistance to blood flow. A theory proposed by this research group into how this 
directly leads to a negative reproductive outcome is one of excess blood flow 
leading to oxidative stress on the feto-placental unit.  
1.5.6.2 Trophoblast Development and implantation 
Early trophoblastic invasion is necessary for implantation of the embryo into the 
uterine wall. Lack of receptivity of the uterus to the conceptus or lack of adhesion 
from embryo to deciduas can result in failed implantation. 
With uNK cells being the predominant leukocyte population in the uterus in the first 
trimester, they have been considered to play a substantial role in implantation and 
early placentation (184). 
It has been suggested that uNK cells are not directly involved in the process of 
implantation (184). uNK cells have been shown, in mice, unnecessary for 
implantation, as uNK-deficient mice became pregnant. However uNK and IL-15 
deficient mice were unsuccessful in pregnancy (175). 
Also, in humans, at site of implantation in ectopic pregnancies, uNK cells are not 
present in the large numbers they are in uterine pregnancies. They are also present 
in large number in the uterus, despite a non-uterine (ectopic) implantation 
(185,186). 
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1.6 Methodological Limitations of Previous Studies 
Flow cytometry is often used to analyse uNK  cells, but this method has some 
disadvantages compared to immunohistochemistry including, the possibility of 
incorporation of other cell types cannot be excluded as the cell sorting is rar ly 100% 
pure,  and  mechanical and enzymatic processing of the tissue will lead to loss of 
information regarding certain antigens and location of cells. Hence there are 
discrepancies between studies using immunohistochemistry and flow cytometry. 
CD69 was found on uNK cells by flow cytometry (187,188) but found predominantly 
on T cells within the endometrium, when using immunohistochemistry (189).   
The advantages of using immunohistochemistry over flow cytometry, is that you are 
able to look at the tissue as a whole and the interaction between cellular activity 
and structure. 
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1.7: Conclusion 
The role and value of uterine natural killer cells in reproductive failure and 
especially recurrent implantation failure is a contentious issue. Since their discovery 
in the endometrium nearly 100 years ago, scientists and clinicians alike have been 
trying to locate their function and influence on the feto-maternal interface. 
The origins of these cells further sits in controversy, with current speculation 
surrounding two main theories. These cells are coming from the peripheral blood 
and trafficking their way into the endometrium to exert their effect or they are 
proliferating and differentiating from cells already resident in the uterus, possibly 
from the stratum basilis which is not shed during menstruation. 
The clinical implication on discovering the origins of these cells is important. There 
are currently many centres offering peripheral blood testing for NK cells (119) and 
attaching prognostic value to these tests, which is yet to be adequately proven. 
Patients with recurrent implantation failure not only have the cost of their emotions 
but the additional costs of these tests to contend with, if the NK cells in the blood 
bare little, if no resemblance bar a shared name to uNK cells then these tests must 
stop and focus needs to be drawn back to the endometrium.  
It is therefore necessary to investigate the character (expression of key receptors 
Ki67, CD16, CD62-L, NKp30) and location of these cells to determine primarily the 
origin of these cells and their spatial relationship within endometrial tissue.   
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1.8: Hypothesis and Aim 
1.8.1 Hypothesis 
We have two competing hypotheses: 
1. Uterine natural killer cells in the endometrial tissue are the result of 
proliferation of resident uNK cells  
2. Uterine natural killer cells in the endometrial tissue are from the trafficking 
of peripheral blood cells into the uterus and their subsequent differentiation 
into their uNK form.  
1.8.2 Aim 
We aim to test these hypotheses by using immunohistochemistry to compare 
antibodies associated with trafficking: L-Selectin, with a marker for peripheral blood 
NK cells, CD16, against makers for proliferation Ki67 and differentiation NKp30, on 
endometrial tissue, using CD56 as the universal marker for natural killer cells. The 
endometrial tissue will be obtained 7 days after the LH surge in the luteal phase as 
this is the window of implantation. 
Furthermore we aim to compare and contrast the occurrence of these markers in 
the tissue of patients already identified as having ‘high’ and ‘low’ density uNK cells. 
Additionally we aim to investigate the spatial relationship of these cells to three 
main structures within endometrial tissue: sub-epithelial, areas with low stromal 
density and perivascular stroma in both groups. 
If hypothesis 1 is correct then the majority of uNK cells will be positive for ki67 and 
NKp30 and very few positive for L- selectin or CD16. Further more in cases with high 
density of uNK cells there will be more KI67 positive cells. 
If hypothesis 2 is correct then the NK cells surrounding the blood vessel will be 
highly positive for L- Selectin and CD16 and those away from the blood vessels in 
areas of stromal oedema and subepitheilial areas will show increased markers of 
differentiation (NKp30) and loss of CD16. 
The Origin and Role of uNK Cells In Patients With RIF                                                  Leena Khan 
 
 
51 
 
CHAPTER 2: METHODS 
 
 
Figure7: Schematic of process from tissue sampling to image analysis, all steps in green carried out by myself 
with resources from the tissue bank also, all steps in black carried out by a member of the department. 
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2.1 Patient Selection 
From a database and tissue bank of 500 patients with endometrial samples taken at 
LH+7, 19 patients were selected who fit the criteria detailed below. The population 
comprised of a group of 9 high uNK cell-density patients and a group of 10 low uNK 
cell-density patients.  
Inclusion Criteria: Patients had to have recurrent implantation failure, defined as 
having a history of infertility and at least 3 failed attempts at IVF including at least 5 
failed embryo transfers of apparently good quality embryos. uNK result of >5% 
(136) for ‘high’ patients and <3% for ‘low’ uNK patients. Patients were biopsied at 
days LH+ 7 +/- 2 days. 
Exclusion Criteria: Mixed diagnosis of both IVF failure and miscarriage. Patients who 
did not have enough paraffin embedded tissue in the tissue bank. 
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2.2 Endometrial Biopsy 
Consent was taken from each patient prior to performing the biopsy.  
At sample collection all women had a transvaginal scan to ensure normal 
endometrial thickness, as assessed by the attending clinician.  
The samples were obtained using a Wallach endometrial sampler to take a biopsy of 
the endometrium.  
Prior to biopsy all women were asked to do a home LH urine test and then the 
biopsy was taken 5 to 9 days after this. These cycles were ‘out-of-treatment’ cycles 
and so not influenced by hormone therapy. The mid-luteal phase was chosen 
because it is important to investigate the pathology in this ‘window of 
implantation’.   
After obtaining the biopsy, the sampler  was immediately transferred to the 
laboratory for freezing and fixation according to the procedure described below:   
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2.3 Endometrial Tissue Reception 
Correct and rapid fixation of tissues is necessary to preserve the structure of the 
tissue and cell morphology. If tissue fixation is delayed it may lead to a decrease in 
the antibody binding capacity(190). This is why all specimens were fixed in 10% NBF 
within 20 minutes of the endometrial sample being taken. 
Equipment 
 Virkon and laboratory plastics (e.g. universals etc) are purchased from 
Liverpool Women’s Hospital (NHS) purchasing department.  
 Forceps and scissors are supplied by Raymond A Lamb Ltd. Manufacturer’s 
address: Units 4 & 5, Parkview industrial estate, Eastbourne, East Sussex, 
BN23 6QE England. 
 TriGene Advance is obtained from Medichem International. Supplier 
address: PO Box 237, Seven Oaks, Kent, TN15 0ZJ. Telephone: 01732 
763555. 
 Neutral Buffered Formalin solution is purchased from Sigma Aldrich. 
Supplier address: Fancy road, Poole, Dorset, BH12 4QH. Telephone 01202 
712300. 
 Biomat2 Recirculating microbiological safety cabinet was purchased from 
Bioquell. Supplier information: Walworth road, Andover, Hampshire, SP10 
5AA. 
 
Laboratory Preparation: 
The surface was cleaned Clean the surface of the microbiological safety class II 
(MCII) cabinet with 1% TriGene Advance solution and dried with absorbent towels. 
The fume hood was set up to contain the following: 
 Universal tube containing 4% neutral buffered formalin (NBF). The Universal 
should be labelled with the date and the RM number. 
 Small weighing boats 
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 Forceps and scissors 
 Discard pot containing 1% Virkon solution. 
 Equipment decontamination container (small plastic container filled to 
approximately 50% capacity with 2% TriGene Advance Solution). 
 Small bottle of sterile PBS 
 A labelled Nunc cryotube and pair of clean forceps are placed in a box of dry 
ice.  
 Liquid nitrogen.  
 
Biopsy Processing Procedure: 
The biopsy was removed from the Wallach endometrial sampler and washed with 
sterile PBS if a large amount of blood was present. Mucous and blood clots were 
removed from the tissue using forceps. Tissue was then placed in a labelled tube of 
4% NBF for 24 hours. If there was excess tissue available then it was frozen. The 
tissue to be frozen was then placed in a clean weighing boat and frozen using liquid 
nitrogen, to be retrieved with forceps and placed in a Nunc cryotube to be stored in 
a -80oC freezer. All information was recorded in a database and consent forms filed 
away in a locked cabinet.  
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2.4 Tissue Processing 
Formalin fixed tissue was dehydrated, cleared then impregnated with paraffin wax 
using the automated Shandon Citadel 1000 processing machine according to the 
schedule detailed below. The total processing time was 18 ¾ hours. 
Processing Schedule: 
Table 4: Schedule of automated processor to process NBF fixed endometrial 
samples: 
Step Solution Time 
1 4% formalin in neutral buffer 45 minutes 
2 60% Ethanol 1 hour 
3 70% Ethanol 1 hour 
4 90% Ethanol  1 hour 
5 100% Ethanol  1 hour 
6 100% Ethanol  1 ½ hours  
7 100% Ethanol  2 hours 
8 Xylene 1 1 hour  
9 Xylene 2 1 ½ hours  
10 Xylene 3 2 hours 
11 Wax 1 2 ½ hours  
12 Wax 2 3 ½ hours 
 
Equipment and solvent information: 
 Citadel processor manufacturer: Thermo electron Corporation. 
Manufacturer’s address: Chadwick Road, Astmoor, Runcorn, Cheshire, WA7 
1PR England 
 Ethanol and xylene are purchased from Chemistry solvent stores (University 
of Liverpool).  
 The wax (Paramat Paraplast Gurr) is  purchased from Histoplast PE which 
comes from Thermo. 
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Preparation of Solvent Containers on Processing Machine: 
To access the processor solvent containers and check solution levels, the raise 
button was pressed. The buttons: rotate or check/fill were used to check each 
solution in turn and they were topped up/changed if required.  
Sample Processing Procedure 
Plastic cassettes were labelled with unique sample ID using pencil. Tissue was then 
retrieved from the formalin and placed into small wire inserts and subsequently 
placed into the plastic cassettes, which were then placed in the processing baskets 
and lowered into slot 1. The processor was started. When the processing cycles 
were completed the cassettes were taken out and placed on the heating element in 
the Shandon Histocentre 3 embedding machine. 
2.5 Embedding 
Paraffin embedding allows adequate demonstration of most tissue antigens with 
the use of antigen retrieval. Some cell antigens do not survive fixation and paraffin 
embedding, and require samples to be frozen with liquid nitrogen. However cutting 
these frozen samples into sections is very difficult, with sequential sectioning 
almost impossible, also the cell morphology and tissue structure is very poor(191), 
this is why paraffin sections are better when needing to analyse tissue structure.  
Procedure 
The endometrial tissue samples were embedded using the Shandon Histocentre 3 
embedding machine. The samples were placed into the heated reservoir of the 
machine to stop the wax from setting.  The sample was removed from the cassette 
using forceps and transferred to a small metal mould on the cooling unit. Hot wax 
was then applied over the sample, then the same cassette that initially housed the 
sample was placed above it, using forceps to compress it over the wax. Tapping of 
the cassette was done to remove any air bubbles. The cassette and wax block was 
left to cool on the cooling compartment. Once fully cooled the cassette and wax 
block separated from the metal mould. They were then stored in the fridge prior to 
having sections cut.  
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2.6 Cutting Sections 
 Micron HM335 rotary microtome is supplied by MICROM company. 
Manufacture’s address: Microm UK Ltd, 8 Thame Park Business Centre, 
Leinman Road, Thame, OX9 3XA. http://www.micron-online.com 
 Microscope slides (super premium twin frost, catalogue number 631-0111) 
are purchased from VWR International. UK based distributor is located at: 
Hunter Boulevard, Magna Park, Lutterworth, Leicestershire, LE17 4XN.  
 Microtome blades (feather, stainless steel S35) are purchased from 
Liverpool Women’s Hospital (NHS) purchasing department.  
 Forceps, paintbrush, section dryer and water bath are supplied by Raymond 
A Lamb Ltd. Manufacture’s address; Units 4 & 5, Parkview industrial estate, 
Eastbourne, East Sussex, BN23 6QE England.  
 
The water bath set was set at 40oC prior to commencing cutting. 
The cassettes were placed into the cutting machine and trimmed back until the 
tissue was seen and then placed in the fridge for cooling. Sections were cut at 4µm 
thick, sequentially and placed on to the surface of the water bath. They were then 
picked up with slide pre-coated with APES (3-aminopropyltriethoxysilane) solution, 
in the same sequence in which they were cut, they were then labelled and left to 
dry. 
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2.7 Immunohistochemistry(192) 
Immunohistochemistry is the detection of antigens using specific antibodies and 
reagents. 
The demonstration of antigens can by greatly improved by the process of antigen 
retrieval. This involves the pretreatment of the tissue sections with an antigen 
retrieval agent, in this case Citrate Buffer in heat (Heat Induced Epitope Retrieval). A 
pressure cooker allows adequate temperature to be reached in order to break 
cross-links formed between proteins in formalin fixation, uncovering antigenic sites.  
  
Background staining can be common in samples that were inadequately fixed. This 
can result in false positive staining, interfering with results. This can be minimised 
with the use of the blocking agent Hydrogen Peroxide prior to the application of the 
primary antibody. This eliminates the endogenous peroxidise activity, which is 
found in many tissues. 
 
Controls were used in every staining run. Positive controls were used to ensure 
staining intensity was consistent and if staining was absent on tissues it was a 
tissue-specific result and not the result of the failure of a specific antibody to stain 
to specific antigen, i.e. to make sure it was a true negative. The positive control was 
most commonly a high uNK density sample which was known to stain well with the 
antibodies used. In all validation staining tonsil was used as the positive control, as 
this is a known positive control for natural killer cells antigens. Negative controls 
were used in the form of IgG antibody, which would highlight any staining due to 
other factors than the primary antibody being studied.  
  
There are two main methods of staining in immunohistochemistry. Direct method 
involves a simple one-step procedure with a labelled antibody reacting directly with 
a specific antigen. This procedure is quick but not sensitive due to poor 
amplification. The Indirect method involves using an unlabelled primary antibody 
(first layer), this reacts with the specific tissue antigen being studied, then a second 
layer is added, the labelled secondary antibody (either goat or mouse polymer HRP 
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– respective species to the antibody being used) which reacts with the first layer. 
This is much more sensitive due to the amplification signal thorough several 
secondary antibody reactions 
 
Procedure 
Prior to immunohistochemical staining, slides were baked for 1 hour at 60C or 
overnight at 37C to improve adhesion.  They were then dewaxed and rehydrated 
(see below) and pressure cooker treated in citrate buffer (pH=6.0 see below), 
brought to boil and  immersed for 1 min. 
Table 5: Dewaxing and Rehydrating schedule: 
Solution 
Time 
Xylene 10mins 
Xylene 10mins 
100% Ethanol 3mins 
100% Ethanol 3mins 
90% Ethanol 1mins 
70% Ethanol 1mins 
Water  
Table 6: Citrate Buffer components: 
Component 
Manufacturer Quantity 
Citric Acid VWR, Magna Park, Lutterworth, Leicestershire, LE17 4XN 12.0g 
dH20  1.5L 
pH 6  VWR, , Magna Park, Lutterworth, Leicestershire, LE17 4XN  
Equipment: 
Staining dishes, Humidified chamber, Cover slips 
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Antibody information: 
Validation for each antibody was performed to find the optimum concentration to 
produce the best results. The varying concentrations are detailed below. 
For each antibody validation staining procedure, tonsil was used a positive control. 
Table 7: Antibodies used and their respective concentrations used in validation: 
Antigen Antibody / 
Catalogue 
Number 
Company Dilution 
For validation 
Polymer Clone 
Ki67 NCL-Ki67-
MM1 
Novocastra 1:100, 1:150, 1:200, 
1:400 
Mouse MM1 
CD56 NCL-L-
CD56-1B6 
Novocastra 1:50 Mouse 1B6 
CD16 DJ13OC Dako 1:50, 1:100, 1:200 Mouse VlFcRlll 
CD62-L AB49508-
500 
Abcam 1:25, 1:50, 1:100 Mouse 9H6 
NKp30 SC-20477 Santa Cruz 1:100, 1:200, 1:400 Goat Sc-24077 
Mouse IgG  MCA928 Serotech 1:100 Mouse IgG1 
Goat IgG  Sc-2028 Santa Cruz 1:200 Goat Sc-2028 
Table 8: Antibodies used and their respective concentrations to investigate 
hypothesis: 
Antigen 
Antibody / 
Catalogue Number 
Company Dilution Polymer Clone 
Ki67 NCL-Ki67-MM1 Novocastra 1:150 Mouse MM1 
CD56 NCL-L-CD56-1B6 Novocastra 1:50 Mouse 1B6 
CD16 DJ13OC Dako 1:100 Mouse VlFcRlll 
CD62-L AB49508-500 Abcam 1:25 Mouse 9H6 
NKp30 SC-20477 Santa Cruz 1:100 Goat Sc-24077 
Mouse IgG  MCA928 Serotech 1:100 Mouse IgG1 
Goat IgG  Sc-2028 Santa Cruz 1:200 Goat Sc-2028 
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For each antibody staining procedure, a known ‘high’ uNK density patient was used 
a positive control. 
Table 9: Solutions used in detection kit 
Detection Kit Kit /cat# Company Dilution Duration 
DAB EnVision (Substrate & 
Chromagen) 
K4006 Dako 1:50 10 mins 
Dako anti-mouse K4003 Dako 1 Drop 10 mins 
Vector IMMPress Anti-Goat Ig 
(Peoxidase) 
MP-7405 Vector 
Labs 
1 Drop 30 mins 
Table 10: Tris Buffered Saline components: 
 
Procedure: 
Slides were placed into a staining dish containing TBS and incubated for 5 minutes 
at room temperature. The slides were then incubated in a 0.3% H2O2/TBS for 10 
minutes at room temperature. The slides were then reincubated in TBS for a further 
5 minutes, and then each specimen was outlined with a hydrophobic marker pen 
(DAKO). The slides were incubated in TBS for 5 minutes. They were then placed in 
the humidifying chamber, and antibody (see table of antibodies above) (made with 
antibody diluent TBS/0.5 % BSA and respective antibody in respective 
concentration) was applied, 50 µl per section. These slides were then incubated 
with the antibody for 60 minutes at room temperature. Antibody was tapped off 
and the slides were then placed in TBS for 5 mins, decanted and refilled with TBS. 
Component 
Manufacturer Quantity 
Tris VWR, Magna Park, Lutterworth, Leicestershire, LE17 4XN 12.0g 
NaCl VWR, Magna Park, Lutterworth, Leicestershire, LE17 4XN 17.4g 
dH20  1.5L 
pH 7.6  add 500mL dH20 to make 2L   
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The slides were then returned to the humidifying chamber and 1 drop of labelled 
polymer-HRP (see table above) was applied. These slides were then incubated for 
30 minutes at room temperature. The polymer was then tapped off and the staining 
dish was filled with TBS, incubated for 5 minutes, decanted and refilled with fresh 
TBS and incubated for a further 5 minutes. The slides were then returned to the 
humidifying chamber and substrate/chromagen solution (20µl/1ml substrate) 50 µl 
per section was applied. After 10 minutes the slides were immersed immediately in 
water to stop the reaction. The slides were then incubated for 1 minute, 30 seconds 
in Gill 2 filtered haematoxylin. The slides were then rinsed with water until the 
water runs clear, then dipped in acid alcohol briefly, and immersed immediately 
back in tap water for several minutes to allow the haematoxylin to “blue”. The 
slides were then put through the dehydration procedure at the following:  
Table 11: Dehydration Procedure: 
Solution Time 
70% Ethanol 1 mins 
90% Ethanol 1 mins 
100% Ethanol 3 mins 
100% Ethanol 3 mins 
Xylene 5 mins 
Xylene 10 mins 
 
Slides were then wet mounted by placing a cover slip upon each section with the 
aid of DPX, and air bubbles removed.  
  
The Origin and Role of uNK Cells In Patients With RIF                                                  Leena Khan 
 
 
64 
 
2.8 Photographing 
Images were photographed using Nikon technology (Nikon eclipse 50i, lens is Nikon 
DSFi1) and NIS elements F2.30 software with the following settings: 
Table 12: Settings used in image capture of stained endometrial sections: 
Feature Level 
Mode  Normal 
Fast(focus)  640x480 pixels 
Quality Capture  1280x960 pixels 
Mode  Autoexposure 
AE Compensation  +1.6v  
Exposure  3ms 
AE Lock  Yes 
Gain  1.70x 
Colour Contrast  High 
Scale  1:1 
 
Autowhite using ‘AE’, focus to full level and capture, all images are saved as .tiff 
files.  
Location of Areas: 
To enable accurate photographing, a log was produced enabling a record to be kept 
for each patient photographed. The purpose of this log was to prevent the same 
area being photographed twice and labelled as two separate areas. Initially a rough 
diagram of the section of tissue was drawn and areas on sequential tissue where 
tissue had not adhered to the slide, or other artefact, was highlighted on the 
diagram, to prevent the photographing of this area. The log also allowed comments 
to be made regarding any unusual staining or interesting differences in staining or 
general tissue appearance. 
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Subepithelial: Tissue was orientated to view an area with epithelial edge, 
corresponding sequential sections to CD56 were also checked to observe adequate 
tissue to photograph. 
Low stromal cell density: As above tissue was orientated to view areas of low 
stromal cell density and the same area located on corresponding CD56 stained 
sections before photographing. 
Perivascular: As above, with areas of high-density vascular structures. 
In all the locations above the confounding influence of these structures overlapping 
in fields were minimised by excluding areas where more than one structure was 
visible in field, where possible. 
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2.9 Image Analysis 
Image analysis software was chosen to analyse micrographs because this offers the benefit 
of reducing inter-observer variability. This method has previously been validated by our 
department. There are two parts to image analysis, firstly to produce a number for the 
count of stromal cells and secondly to count positively stained cells, with the aim to 
produce a percentage stromal staining for each micrograph, each stain for each area to be 
looked at. 
The advantage of producing three micrographs per stain per location, would enhance 
accuracy by enabling to use this average in the analysis of results. 
Equipment Information 
Setup 1 
 Nikon Biophot Microscope, Nikon Corporation, Tokyo 100-8331, Japan 
 Nikon DS-5M camera head 5M pixel, Nikon Corporation, Tokyo 100-8331, Japan 
 Nikon Digital Sight DS-U1 digital control unit, Nikon Corporation, Tokyo 100-
8331, Japan 
 Nikon C-Mount TV adaptor 0.6x, Nikon Corporation, Tokyo 100-8331, Japan 
 Eclipsenet software, developed by Laboratory Imaging s.r.o. for Nikon 
Instruments Europe B.V., 1170AE Badhoevedorp, The Netherlands       
 Adobe Photoshop CS2 software, Education Version.  Adobe Systems 
Incorporated. 345 Park Avenue, San Jose, CA 95110-2704 USA www.adobe.com 
 
Setup 2 (supplied by Jencons-PLS) 
 Nikon Eclipse 50i Microscope, Nikon Corporation, Tokyo 100-8331, Japan  
 Nikon DS-Fi1 digital camera Head 5M pixel, Nikon Corporation, Tokyo 100-8331, 
Japan 
 Nikon Digital control unit DS-U2 USB, Nikon Corporation, Tokyo 100-8331, Japan 
 Nikon C-Mount TV adaptor, 0.63x, Nikon Corporation, Tokyo 100-8331, Japan 
 NIS-Elements-F software, developed for Nikon Instruments  
 Adobe Photoshop CS3 software, Education Version.  Adobe Systems 
Incorporated. 345 Park Avenue, San Jose, CA 95110-2704 USA www.adobe.com 
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Both systems 
 Personal computer (minimum specification 1GB RAM, 2.8GHz processor) 
 WCIF Image J     http://www.uhnresearch.ca/facilities/wcif/fdownload.html 
  
Procedure: Stromal Count 
Adobe Photoshop was used to prepare the micrographs for image analysis. Each file 
to be analysed was opened in Adobe Photoshop and had each gland and vessel 
manually removed by using the Magic Lasso tool, creating an outline of each 
structure, to be deleted. Following this, it was important to remove the DAB 
staining to just leave the stromal cells. This was achieved by using the Magic wand 
tool, to select and delete areas of ‘brown’ positive staining. At each step images 
were saved in TIFF format, to prevent detail being lost in other compression 
formats.  
 
To obtain a count for the stromal cells, ImageJ software was used. Each file with 
DAB removed (stroma images) were opened in ImageJ and subsequently saved as 8-
bit grey scale images (Image|Type|8 bit). This allows a threshold to be applied to 
the image (Image|Adjust|Threshold) set at level which accurately represents the 
majority of cells visable in ‘red’ without background being selected also. The 
threshold number was noted to enable adjustment at a later stage if necessary. If 
needed ‘smooth’ function was applied to smooth edges and have more ‘cellular’ 
outlines. The threshold was then applied. If a significant proportion of the cells are 
patchy they can be filled using Process|Binary|Fill.  To enable distinct cells to be 
counted, instead on one cluster, cells were separated using the watershed function 
(Process|Binary|Watershed). To count the number of nuclei, Analyze Particles 
(Analyze|Analyze Particles) was used with the following settings (Setup 1 Size: 
0.0015-0.1, Setup 2 Size: 36-2250, with both setups using the following:  Circularity: 
0.3-1, Show outline, Clear results, Summarise). An outline of the nuclei was then 
displayed, allowing, after inversion, colour merging of this image onto the original, 
to check the majority of cells were correctly identified. A summary box showing 
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total count was then available, providing the total number of stromal cells 
identified. This number was noted down. 
 
Procedure: positively stained cell count 
ImageJ software was also used for the identification of positively stained cells. Each 
orinigal file was opened up and positive cells counted using the ‘point picker’ tool 
(Plugins|Particle Analysis|Pointpicker), after applying a grid (Plugins|Particle 
Analysis|Grid Average per point = 15170, pixel width = 2). For cytoplasmic markers, 
NKp30 and Ki67, positive stained cells are those in which there is a brown stained 
nucleus instead of the haematoxylin stained blue stromal nuclei. Cytoplasmic 
markers CD56, CD16 and CD62-L/L-Selectin are cytoplasmic markers.  Positively 
identified cells were marked with a cross by left-mouse clicking on the cell. Markers 
can be removed and moved by selecting corresponding buttons on the menu bar. 
When finished selecting positively stained cells, a results box was obtained by 
selecting ‘show’ on the menu bar. The total number of cells identified was noted.  
To obtain a percentage of stromal cells stained divide the stained cell count by the 
total stromal count and multiplied by 100.  
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2.10 Statistical Methods Used For Analysis 
The statistical analysis was carried out using SPSS version 16.  
More than one measurement was performed per sample patient. This varied from 2 
to 9 replicates per condition. The mean value was calculated for each condition for 
each individual and this value was used in the analysis.  
To detect a relationship between the age of the sample population and uNK cell 
density, a correlation analysis, using Spearman rank was performed. 
To validate my measuring of the density of uNK cells per field, comparisons were 
made against experienced  cell counters within the department. Bland-Altman plots 
were produced to highlight any systematic differences in cell counts resulting from 
methodical differences. 
Graphical representation of the expression of each antibody in each location was 
then prepared categorising by ‘high’ or ‘low’ uNK cell density group, with errors 
bars at 95% confidence intervals.  
Analysis of Variance was used with a contrast. There was a degree of repeated 
measurement in the analysis because each woman contributed data for each 
antibody in three conditions. Therefore study patient number was used as a 
covariate, a practical measure to overcome any effects of repeated measurements. 
Post hoc tests were not possible with a covariate, therefore a simple contrast was 
used to compare the location sites, with epithelium set as a reference group.  
An interaction term was also included to determine whether the difference in 
location were attributable to uNK cell density groups. This interaction term was not 
significant in any of the analyses and so is not presented in the results. 
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CHAPTER 3: RESULTS 
 
 
3.1 Patient Demographics 
 
 
Table 13: Demographic distribution of the selected patients: 
Patient Demographics High Group Low Group 
Age 37 
(n=23-45) 
37.5 
(32-41) 
uNK count 7.7 
(6.1-11) 
2.2 
(0.3-3.1) 
Number (n) 9 10 
IVF Cycles  3 
(3-6) 
4.5 
(3-12) 
Embryo Transfers 8 
(6-12) 
8.5 
(6-33) 
 
 
The median values for embryo transfer and age were the same amongst both ‘high’ 
and ‘low’ density uNK groups. Additionally the median number of IVF cycles 
undertaken and previous embryo transfer attempts by these patients were similar 
in both the ‘low’ and ‘high’ uNK groups. 
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Figure 8: Graph illustrating the relationship between age and uNK % in recurrent implantation failure 
patients. 
 
 
Spearman rank correlation was performed comparing age and IVF failures in 
patients to determine whether ‘age’ would be a confounding variable (see Figure 8 
above). Many believe that the quality of eggs produced by females of a younger age 
are better than women of an older age (193). On a database of 101 recurrent 
implantation failure patients, statistical tests were performed to detect the level of 
correlation. A correlation coefficient of -0.087 was detected which had no statistical 
significance (p=0.387). This shows, that in our sample population, uNK cell values 
were not attributed to age.  
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3.2 Image Analysis Validation 
Bland Altman Plots 
  
Figure 9: Bland Altman plot for JD/LK uNK counts 
The stromal count (counting stromal cells) was based on a selection of 78 images, 
and compared to JD (who was already validated using the same procedure and 
same selection of images) to ensure direct comparison (see Figure 9 above). As can 
be observed on the plot above most values centre closely the mean, outliers are not 
common. 
 
Figure 10: Bland Altman plot for AT/LK uNK counts 
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The uNK count (counting positive cells) was based on a selection of 61 images, and 
compared to AT (who was already validated using the same procedure and same 
selection of images) to ensure direct comparison (see Figure 10 above). As can be 
observed by the plot above there is a close association between both interpreters 
at lower levels of uNK cell counting, with observer variance increasing at higher 
levels of cell density, as can be expected. 
 
Figure 11: Bland Altman plot for AK/LK uNK counts 
The uNK count (counting positive cells) was based on a selection of 61 images, and 
compared to AK (undergoing validation at the same time point) (see Figure 11 
above) using the same procedure and same selection of images to ensure direct 
comparison. As can be observed on the plot above there is a close association 
between both interpreters, ensuring consistency of results. 
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3.3 Micrographs 
 
Sample Results: 
 
Low ‘uNK’ patients:  
 
Epithelial Edge 
 
      
 
      
 
      
 
Figure 12: Micrographs showing subepithelial location of uNK Cells in a ‘Low’ patient, with the 
following stains: a) Ki67, b) CD56, c) NKp30, d) CD62-L, e) CD16 f) IgG Mouse (negative control) 
 
 
 
  
a b 
c d 
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Perivascular: 
         
 
 
         
 
 
         
 
Figure 13: Micrographs showing perivascular location of uNK Cells in a ‘High’ patient, with the 
following stains: a) Ki67, b) CD56, c) NKp30, d) CD62-L, e) CD16 f) IgG Mouse (negative control) 
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Areas of low stromal density (Oedema): 
 
 
      
      
      
 
 
 
Figure 14: Micrographs showing areas of low stromal density of uNK Cells in a ‘Low’ patient, with the 
following stains: a) Ki67, b) CD56, c) NKp30, d) CD62-L, e) CD16 f) IgG Mouse (negative control) 
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High ‘uNK’ patients: 
 
 
Epithelial Edge:  
 
 
    
    
    
 
Figure 15: Micrographs showing subepithelial location of uNK Cells in a ‘High’ uNK patient, with the 
following stains: a) Ki67, b) CD56, c) NKp30, d) CD62-L, e) CD16 f) IgG Goat (negative control) 
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Perivascular: 
 
 
    
    
    
 
 
Figure 16: Micrographs showing perivascular location of uNK Cells in a ‘High’ patient, with the 
following stains: a) Ki67, b) CD56, c) NKp30, d) CD62-L, e) CD16 f) IgG Mouse (negative control) 
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Areas of low stromal density (Oedema): 
 
 
     
     
     
 
 
Figure 17: Micrographs showing areas of low stromal density of uNK Cells in a ‘High’ patient, with the 
following stains: a) Ki67, b) CD56, c) NKp30, d) CD62-L, e) CD16 f) IgG Goat (negative control) 
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3.4 Graphs and Statistical Results 
 
 
 
Figure 18: Graph illustrating difference in antibody staining in ‘High’ and ‘Low’ uNK cell density 
population in peri-epithelial areas. 
 
As demonstrated from the graph above (see Figure 18 above), as expected uNK 
(CD56+) percentage in the ‘high’ uNK cell density group were significantly higher 
than uNK (CD56+) percentage in the ‘low’ uNK cell density group. This difference 
was also expressed in the Ki67 staining.  
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Figure 19: Graph illustrating the difference between CD56 counts in ‘High’ and ‘Low’ uNK cell density 
populations in all observed locations. 
 
There was significant difference in the staining of CD56 in all three locations 
between the ‘high’ and ‘low’ uNK groups (see Figure 19 above). This difference was 
expected. The error bars at 95% confidence show no overlap. The locations show a 
similar pattern of staining, with the least percentage positive stained of CD56 
observed near epithelium, and the maximal staining observed in the perivascular 
areas. 
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Figure 20: Graph illustrating the difference in antibody stained per location in the ‘Low’ uNK cell 
density group. 
 
The expression of CD62-L (L-Selectin) in the ‘low’ uNK group was minimal. The 
expression of CD16 in the ‘low’ uNK group was also relatively low (see Figure 20 
above). However the levels of Ki67 and NKp30 were significantly higher than CD62-L 
in areas surrounding epithelium and vessels. 
 
There were no significant differences in the staining of Ki67, NKp30 and CD56 in all 
three locations. However there were higher levels of CD56 than CD16 in areas 
surrounding vessels and epithelium. 
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Figure 21: Graph illustrating the difference in antibody stained per location in the ‘High’ uNK cell 
density group. 
 
 
The expression of CD62-L here in the ‘high’ uNK group is minimal, with the 
expression of CD16 also relatively low (see Figure 21 above). There were no 
significant difference between the staining of NKp30, Ki67 and CD56 in all three 
locations. However, there was a difference between CD56 and CD16 staining in all 
three areas, most remarkably in areas near vasculature. Also, in perivascular areas 
there is significant difference between CD16 and CD62-L and the other stains, CD56, 
Ki67 and NKp30. 
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Table 14: Results of analysis of data collected in image analysis software in each stain used in both ‘high’ and ‘low’ uNK populations. 
Univariate analysis of variance (ANOVA) showed significant differences between ‘high’ and ‘low’ uNK cell density groups in antibody staining and 
locations. Analysis was performed with patient study number as a covariate. A simple contrast was used to compare antibody staining at each location 
with epithelium as a reference group.   
Antibody High/Low Group Location    Comparison of Location Sites 
Overall % Mean 
Difference 
 
% Significant 
Difference  
(p-value) 
Overall Significant  
Difference Between 
Locations 
(p-value) 
    Location Contrast to 
Explore 
Difference 
Significance of 
contrast 
(p-value) 
CD16 0.652 0.013 0.033 Oedema vs Epithelium 0.804 0.01 
Vessel vs Epithelium 0.468 NS 
CD62-L  /  
L-Selectin 
0.026 NS 0.040 Oedema vs Epithelium 0.04 0.045 
Vessel vs Epithelium -0.007 NS 
CD56 4.8567  
 
0.000 0.011 Oedema vs Epithelium 1.283 NS 
Vessel vs Epithelium 2.099 0.003 
Ki67 3.354 0.000 0.009 Oedema vs Epithelium 0.201 NS 
Vessel vs Epithelium 2.770 0.006 
NKp30 4.366 0.000 0.067 Oedema vs Epithelium 0.018 NS 
Vessel vs Epithelium 2.451 0.023 
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CHAPTER 4: DISCUSSION 
This project describes the endometrial expression of markers of cell differentiation 
and proliferation in cases of RIF with, and without high uNK density. 
We have examined the distribution of each cell marker. This allows us to comment 
on the spatial differentiation of NK cells and the implications for function of that 
distribution. We can also comment on whether cases of high uNK cell density are 
associated with markers of uNK cell trafficking and/or proliferation. This allows us 
to address a controversial area of clinical relevance in endometrial biology. 
 
 
4.1 NK Cells distribution 
CD56+ cells were seen higher in areas around vessels than in other locations 
(p=0.003). This finding is consistent with theories relating to the function of these 
cells (181). Their close proximity to vessels makes them ideally situated to engage in 
promoting vasculature development. Perhaps this early development of arteries 
leads to a highly oxygenated state, which is detrimental to the developing embryo. 
In both the ‘high’ and the ‘low’ uNK groups the majority of staining for CD56+ cells 
was observed around vasculature. The relative decrease of uNK cells observed at 
the epithelial edge could be a reason for the high incidence of implantation failure 
in these patients. The epithelial edge of the endometrium is part of the foetal-
maternal interface, and the first point of call in adhesion of the blastocyst to the 
epithelial edge. If uNK cells assist in the invasion of the trophoblast it could be 
possible that in this group of patients they are not situated most optimally. 
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4.2 Trafficking 
The majority of uNK cells have the phenotype CD56brightCD16-, in contrast to the 
majority of peripheral blood NK cells, CD56dimCD16-. The results show low levels of 
CD16+ cells in the endometrium. This is consistent with previous reports (93). If 
peripheral blood NK cells were trafficking to the endometrium they would have to 
be of the subtype CD56brightCD16-, which form only 10% of the peripheral blood 
NK cells, this would indicate a selection method to only recruit the 
CD56brightCD16+ phenotype. 
The difference observed in the CD16 distribution across the three locations showed 
a difference in the trends of the other antibodies studied. With a significant 
increase in these cells seen in areas of low stromal density (oedema) compared to 
subepithelial areas (p=0.01). This association could be explained by the association 
of lymph vessels with areas of low stromal cell density which was general 
observation when carrying out this research. CD16 antigen is not specific to NK 
cells, it stains other leukocytes such as monocytes, macrophages and neutrophils.  
Observing staining whilst photographing it became obvious that some CD16+ cells 
were not NK in morphology, but resembled neutrophils and monocytes also. When 
looking at the overall numbers of CD16+ cells, we must note this may include other 
lymphocytes stained, this makes the actual number of CD16+ NK cells even smaller. 
Very few stromal cells stained positive for CD62-L (L-Selectin), this is very strongly 
suggestive that NK cells in the endometrium are not the result of migration, 
trafficking of peripheral blood NK cells, from the blood into the endometrium. One 
would expect the adhesion module to be present on all cells migrating from the 
blood, as it is necessary for successful adherence to endothelial lining of vessels and 
subsequent migration (152). 
Previous work carried out with L-Selectin was performed in mice (156), and in vitro, 
and may not reflect what is actually occurring at the foetal-maternal interface, as 
murine models exhibit different modes of placentation (80).  
With these two results it becomes increasingly more suggestive that trafficking of 
peripheral blood NK cells into the endometrium does not explain the high numbers 
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of these cells in the endometrium. Importantly, the group with high density of uNK 
cells did not have more L-selectin positive cells than the low uNK cell density group. 
Further more the L-selectin positive cells were not clumped round blood vessel as 
would have been expected if trafficking had occurred. Hence the increased uNK cell 
density seen in some women did not appear to be the result of trafficking. 
Given the extremely small number of stained cells for L-Selectin, it would be 
understandable to consider the validity of the antibody used to detect this receptor. 
However, all antibodies used were validated, using known positive controls. 
Furthermore in one patient from the ‘high’ group, on microscopy, a dense area of 
leukocyte infiltrate was noted, as these cells appeared atypical and stained heavily 
with CD62-L (see Figure 22 below). These findings were confirmed by H&E 
(haematoxylin and eosin stain) where the area was structurally abnormal. However 
this area did not stain in a similar fashion with CD56, so these cells were not NK 
cells. (Please see micrographs below) 
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Figure 22: Micrographs showing 
the staining of an area of 
lymphocyte infiltration with the 
following antibodies to a) CD62-L, 
b) CD56, c) CD16. 
Staining in micrograph a does not 
correlate with staining in the 
other two stains, indicating that 
the staining is not of NK cells or 
CD16+ Lymphocytes. 
a 
c 
b 
The Origin and Role of uNK Cells In Patients With RIF                                                 Leena Khan 
 
 
89 
 
Another explanation for our data, is that if these cells were migrating, that they, 
upon activation would ‘lose’ their L-Selectin by binding to endothelial lining of 
vessels (194). Levels of NKp30+ cells (differentiation and activation marker) were 
found to be much higher in the stroma than that of CD62-L, so the majority of these 
cells were activated. However, the lumens of vessels at LH + 5-9 are not developed, 
and many still exist as endothelial cords only. This means that there was unlikely to 
have been enough time for the cells to migrate in this fashion to ‘lose’ their L-
Selectin status. 
Previous work on finding L-Selectin expressed on trophoblast does not necessarily 
suggest any direct function of this receptor to uNK cells, as endometrial epithelial 
cells are found to express a ligand to L-Selectin, which makes embryo adhesion 
more efficient (195).  
Work on leukocyte migration in mice, in other tissues with inflammation, has shown 
that L-Selectin is necessary for migration of leukocytes (196). Migration of 
leukocytes is severely inhibited in L-Selectin deficient mice, and those challenged 
with L-Selected neutralising antibodies and L-Selectin IgG chimera (197).  
When  mice were injected with thioglycollate (196) into their peritoneal cavity to 
induce an inflammatory response, inhibited leukocyte migration was observerd  in 
L-Selectin deficient mice, with a significant difference compared to controls 
(p=0.03). This shows that L-Selectin is needed in adequate migration of leukocytes 
to non-primary lymphoid organs. These mouse experiments  can be related to the 
endometrium, albeit a unique tissue within the body, as similar migration pathways 
would be employed if leukocytes were trafficking here. The paucity of L-Selectin 
detected in this study suggests that leukocytes, NK cells from peripheral blood, are 
not migrating from the peripheral blood to the endometrium to any significant 
degree. 
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4.3 Proliferation 
 
The marker for proliferation of uNK cells, Ki67 was significantly different between 
‘high’ and ‘low’ uNK groups (p<0.0001). It was also found to vary statistically 
between locations (p=0.009) and was significantly higher in areas around vessels 
compared to areas near epithelium (p=0.006). This suggests that those uNK cells 
surrounding vessels are proliferating. The locality of these proflierating cells could 
suggest that they have a role in vascular remodelling or they are proliferating near 
to vessels because this is their mode of transport into the endometrium. The later is 
unlikely due to the low levels of CD16+ and L-Selectin+ cells that were found in 
these areas, as discussed previously. 
The origin of uNK cells, much debated, can be suggested by the results of our study. 
The levels of Ki67 found in previous studies (154) as high as 40% of uNK cells, 
suggesting that these cells proliferate and differentiate from cells already resident 
in the stratum basalis, which is not shed in menstruation. 
Lynch et al.(198) have found heamatopoetic stem cells phenotype in the 
endometrium. These cells have the ability to differentiate and proliferate into uNK 
cells. Cho et al.(199), also showed the presence of stem cell markers in the stroma 
of the basalis. This evidence, along with our and others recognition of Ki67 stained 
uNK cells (93), is strongly supportive of the concept that uNK cell arise of 
proliferation and differentiation of haematopoetic stem cells within the 
endometrium. 
 
 
 
 
 
  
The Origin and Role of uNK Cells In Patients With RIF                                                 Leena Khan 
 
 
91 
 
4.4 Differentiation and Activation of NK cells. 
Numbers of cells staining positive to NKp30 were significantly higher in the ‘high’ 
uNK group, than the low (p<0001). 
We found higher number of NKp30+ cells in areas of vessels compared to 
epithelium (p=0.023), with no significant difference between oedema and epithelial 
areas.  
The NKp30 staining confirms that these cells are activated in the endometrium at 
LH + 5-9. During this ‘window of implantation’ it would be hard to ignore that these 
cells have a large role in the process of implantation. Their high numbers and 
activated state in patients with recurrent implantation failure, most likely plays a 
role in the pathology of this unique condition. 
Our staining of NKp30 differed to previous results from other studies. Manaster et 
al. (148) found no positive cells for NKp30 without prior activation of the 
endometrium by IL-15, in vivo. Ponnampalam et al.(149), only found NKp30 staining 
on the glandular epithelium and luminal epithelium and the staining was 
cytoplasmic, rather than our nuclear staining. Manaster et al. (148) used flow 
cytometry and thus may have lost some cells during the digestion needed to 
separate the cell from solid tissue prior to flow cytometry or during the “gating” or 
cell size sorting. Also nuclear staining will be far less effective in detecting than 
cytoplasmic staining using flow cytometry.  
Although Ponnampalam et al.(149) used the same antibody to detect NKp30 (sc-
20477) as we did, they used it on frozen sections. To determine whether the 
difference in our staining were due to the difference in tissue type used we 
performed immunohistochemistry with the same antibody on frozen sections on a 
small selection of our study sample. The results were similar to paraffin staining and 
are shown below. The staining did not change, it remained nuclear and was not 
shown in glandular epithelium or luminal epithelium. This persistent difference may 
be explained by an increase in background staining observed in Ponnampalam et 
al.(149) micrographs, as goat polymer in the detection of NKp30 can produce 
background staining more than mouse polymer systems. 
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Figure 23: Micrographs of frozen sections stained with NKp30 and Negative control, IgG Goat.  
a)’Low’ patient with NKp30 staining, b) ’Low’ patient with IgG Goat staining, c) ’High’ patient with 
NKp30 staining, d) ’High’ patient with IgG Goat staining. These micrographs were cut and stained by 
an experienced member of our department. 
To address the differences observed by Manaster et al. (148), we looked at the 
staining pattern of NKp30 in deciduas, of varying weeks gestation in first trimester 
(see Figure 23 above, Figure 24 below). If their NKp30 positive peaks were only 
observed once stimulated with IL-15, in vitro, it could be that changes in nuclear to 
cytoplasmic staining could occur at different differentiated levels for these cells. 
However, no change in staining pattern was seen in any of the decidual staining, 
(see below). We must conclude from this that our staining of novel NKp30, is the 
first to be truly observed in frozen and paraffin late-secretory phase endometrium 
and first trimester decidua. 
 
c d 
a b 
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Figure 24: Micrographs of decidua taken at different gestations in the first trimester stained with 
CD56 or NKp30. a) 6 weeks - CD56, b) 6 weeks - NKp30, c) 8 weeks - CD56, d) 8 weeks - NKp30, e) 10 
weeks - CD56, f) 10 weeks - NKp30, g) 12 weeks - CD56, h) 12 weeks - NKp30. These micrographs 
were cut and stained by an experienced member of our department. 
a b 
e f 
d c 
h g 
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CHAPTER 5: CONCLUSION  
The results of this study strongly suggest the origin of uNK cells population in 
patients with recurrent implantation failure are within the endometrium and 
migration of peripheral blood cells into the endometrium is unlikely to be 
significant. The majority of peripheral blood NK cells differ phenotypically (being 
CD16+) from uNK cells and are more cytotoxic in their behaviour. However the 
minority population of peripheral blood NK cells share the same phenotype as the 
observed uNK cells. A strong competing hypothesis was that these cells migrate to 
the uterus, in order to do this they use the homing marker, L-Selectin to adhere to 
endothelial cells. Our results found very little CD16+ and L-Selectin+ cells in the 
samples selected, with possible explanations discussed previously, the most likely 
being that these cells are not trafficking to the uterus from peripheral blood. 
This study also showed that these cells are activated and proliferating in the 
endometrium, mostly in areas surrounding vessels. Previous work in the same 
laboratory found a positive correlation between uNK cells density in endometrial 
vasculature and blood flow (181). However, this correlation could have been found 
because the uNK cells secrete angiogenic factors that promoted angiogenesis or the 
uNK cells could have trafficked through the vessel walls and hence be located next 
to the vessel.  Our new data favours the suggestion that uNK cells have a functional 
role and aid in vascular remodelling. 
 
 
 
 
 
 
 
 
The Origin and Role of uNK Cells In Patients With RIF                                                 Leena Khan 
 
 
95 
 
5.1 Limitations in Methodology. 
Immunohistochemistry was chosen as the method to detect these receptors and 
their expression by uNK cells. We also wanted to gain information about the 
distribution of these cells in three specific locations. The disadvantage to our 
method was the inability to label cells with both CD56 and another marker, so one 
could ensure each labelled cell was a uNK cell when comparing each marker. One 
way of overcoming this was to use sequential sections, with micrographs of each 
area being in close proximity to both a uNK cell stain and another antibody stain. 
However, the sections were only able to be cut at 4m due to the necessity of 
sequential sections, cutting at 3m was not possible. It became clear on 
photographing stained sections that although the microstructure of the section was 
similar to sequential sections, the variations between cells made it difficult to locate 
corresponding cells on sequential sections.  
A way to overcome this would have been to do double staining on the sections. 
Some samples of the sample population were sent to labaratories in Newcastle to 
be double stained, as they have double staining validated, to see if it would be a 
viable option (see Figure 25 below). 
The results of the duel-labelling are shown below: 
 
a 
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Figure 25: Micrographs showing cystoplasmic and nuclear double staining. Cystoplasmic, brown 
staining is CD56, nuclear staining, Silver-Grey is Ki67. a) Patient from ‘low’ uNK group b) patient 
from’high’ uNK group. These micrographs were cut and stained by an experienced member of a 
collaborative department. 
As you can see the duel labelling has worked as some cells were clearly CD56+ and 
ki67+, but the lack of counterstain with haematoxylin means that we are unable to 
see structures such as glands, vessels and epithelial edge. Consequently this 
method was unable to be used because we would lose information on location if 
using this method. 
 
5.2 Clinical Implications  
With results suggesting that NK cells are not trafficking from peripheral blood, there 
is no scientific rationale for clinical sampling of peripheral blood for NK cell testing, 
as it cannot accurately reflect what is happening in the endometrium of these 
patients. Additionally consequent treatment consisting of NK cell modification in 
the systemic circulation should cease, as it is not without unwanted and potentially 
harmful side effects (118). 
Advances in diagnostic tests and treatment should move away from peripheral 
blood NK cell augmentation to uNK cells. With further research in the area of uNK 
b 
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cells and recurrent implantation failure, hopefully an endometrial factor will be 
found that treatment options can be tailored to. 
 
5.3 Future Directions  
The results of this study need to be replicated on a larger scale to strengthen 
conclusions made. It would be beneficial to look at endometrium throughout the 
menstrual cycle, with the receptors used, to identify the pattern of behaviour for 
these cells. To conclusively reject the competing hypothesis of migration of these 
cells from peripheral blood, it would be useful to study, not only L-Selectin, but 
other leukocyte trafficking markers, at various stages in the cycle. 
The activation and proliferation of these uNK cells in the unique and dynamic tissue 
of the endometrium cannot be ignored, and their functional role at the feto-
maternal interface must be determined. Prospective observational study of 
endometrial factors and IVF outcome would help to determine endometrial factors 
in IVF failure.  
Elucidation of the multifactorial causes for recurrent implantation failure will 
alleviate the emotional distress of this devastating disease for these patients. 
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HIGH NUMBERS OF UNK CELLS LEAD TO A HOSTILE ENDOMETRIAL ENVIRONMENT 
FOR IMPLANTATION IN PATIENTS WITH RECURRENT IMPLANTATION FAILURE 
L Khan, A Karam, J Drury, A W Tang, M Turner, S Quenby 
University of Liverpool, Liverpool, United Kingdom 
 
Recurrent implantation failure (RIF) is thought to be the worst end of a spectrum of 
disorders of placentation. Natural Killer (NK) cells have been associated with RIF, 
however, the importance of endometrial compared to peripheral blood NK cells is 
debated.  
Hypothesis: uNK cells are originate in the endometrium and do not occur due to 
trafficking of peripheral blood NK cells 
Methods: 20 patients with recurrent implantation failure (RIF: >5 failed embryo 
transfers) had endometrial biopsies taken at LH+ 7-9. Serial paraffin sections were 
stained using immunohistochemistry with the following: CD56 (all NK), CD16 and L-
Selectin (peripheral NK), NKp30 (differentiated NK) and Ki67 (proliferation). The 
same areas in samples were analysed using a semi-quantative, single-blind 
approach observing areas surrounding vessels, oedema, and epithelium.  Cases with 
high-uNK or low-uNK cell density were compared. 
Results: Minimal numbers of CD16+ and L-Selectin+ cells were observed in all cases. 
In the high-uNK cases, a substaintial increase in NKp30+ cells were observed in 
areas surrounding vessels, with a slight increase of Ki67+ cells. 
Conclusion:  Low expression of markers for peripheral NK cells at LH+ 7-9 challenges 
the theory that uNK cells migrate from the blood. On the other hand, in patients 
with RIF and high-uNK cell density, differentiated and activated uNK cells surround 
vessels. The differentiation of resident uNK cells could be involved in angiogenesis 
and the induction of a hostile endometrial environment.  
 
Abstract published as follows: 
L. Khan, A. Karam, J. Drury, A. Tang, M. Turner, S. Quenby. High Numbers of Uterine 
Natural Killer Cells Lead to a Hostile Endometrial Environment For Implantation in 
Patients with Recurrent Implantation Failure. Arch Dis Child Fetal Neonatal Ed 
2009;94:Fa58-Fa71
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High numbers of uNK cells lead to a hostile endometrial environment for implantation in patients with 
rcurrent implantation failure. 
 L. Khan, A. Karam, A. Tang, J. Drury, M. Turner, S. Quenby 
 
Department of Reproductive and Developmental Medicine, University of Liverpool, Liverpool Women’s 
Hospital, Liverpool, L8 7SS 
 
Background: Natural Killer (NK) cells have been associated with Recurrent implantation failure (RIF), 
however, the importance of endometrial compared to peripheral blood NK cells is debated.  
Methods: Endometrial biopsies (LH 7-9) from 19 patients with RIF were stained with the following: CD56 
(all NK), CD16 and L-Selectin (peripheral NK), NKp30 (differentiated NK) and Ki67 (proliferation). Areas 
surrounding vessels, oedema, and epithelium were observed in patients with high-uNK or low-uNK cell 
density groups. 
Results:  Minimal numbers of CD16+ and L-Selectin+ cells were observed universally, with substantial 
increases in NKp30+ (p=0.023) and Ki67+ (p=0.006) observed in areas surrounding vessels in both groups. 
Conclusion:  Low expression of peripheral NK markers challenges the theory that uNK cells migrate from 
the blood. In both high and low-uNK cell density patients, differentiated and activated uNK cells surround 
vessels. The differentiation of resident uNK cells could be involved in angiogenesis and the induction of a 
hostile endometrial environment.  
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